Faculty

Dr. Abdul Rahman Zargul

Consultant Medical Oncologist , Hamad Medical Corporation | Qatar

Dr. Abdul Rahman Zar is currently a Consultant Medical Oncologist and Assistant Fellowship Director at the National Cancer Care Center and Research (NCCCR) of Hamad Medical Corporation. He is the Lead of Head and Neck MDT and CORE member of GI MDT. Dr Abdul Rahman Zar has received his medical degree from the Khyber Medical University, Peshawar, Pakistan.

Dr. Abdulaziz Alhamad

Radiation Oncologist , Prince Sultan Military medical city | Saudi Arabia

AbdulAziz AlHamad, MD FRCP (C)–Radiation Oncology is a Consultant of Radiation Oncologist at Prince Sultan Military Medical City, Saudi Arabia. Dr. Abdulaziz AlHamad 's top areas of care are X-ray, Ultrasound, Computed Tomography (CT), Nuclear medicine including positron emission tomography (PET), and magnetic resonance imaging (MRI) to diagnose and/or treat diseases.

Dr. Abdulrahman Sulaiman Bin Sumaida

Chief of Radiotherapy , Tawam Hospital | United Arab Emirates

Dr Abdul Rahman Bin Sumaida is currently chief of Radiation Oncology at Tawam hospital AlAin, UAE. Dr Sumaida did his medical education From Milan University –Italy. He completed Radiation oncology residency training program from the Cape Town University. He did clinical Research fellowship in head and neck and Gastrointestinal malignancies from South Africa. He further completed Fellowship in SRS and SBRT from Halifax Canada. He is currently caring patient with head and neck and breast cancer .He is involved in multiple ongoing research. and he is involved in teaching junior staff, and involved in multiple committees

Dr. Abraham Zachariah

Senior Radiotherapy Technologist , Tawam Hospital | United Arab Emirates

Abraham qualified with a degree in Medical Radiological Technology in 2000 from the Mahatma Gandhi University in Kerala, India. With a keen interest in radiotherapy, he gained valuable experience in multiple reputed Oncology centres, before joining the team at Tawam hospital in 2008. Currently he is a Senior RTT in the Radiotherapy department and responsible to manage the introduction of new techniques and technology, as well as the training of all staff members. He is an expert in the field of linac based imaging and image guided radiotherapy, with a keen interest in stereotactic radiotherapy.

Dr. Adam Nelson

Consultant Physician , Tawam Hospital | United Arab Emirates

Dr. Adam Nelson is currently working at Tawam Hospital in the capacity of a consultant radiologist in Al Ain. UAE since 2022-present. He is involved in Neuro-oncology and Neurology MDTs at Tawam Hospital. He obtained his FRCR in 2013 and CCT in 2016 and has worked as a consultant radiologist since Then. He completed his training in Clinical radiology with a fellowship in Neuroradiology from the Walton centre, institute of neurosurgery and neurology in Liverpool. He has since then worked as consultant Neuroradiologist at the Institute of neurosurgery and neurology at Queen Elizabeth hospital in Glasgow and thereafter at the Royal Victoria hospital in Belfast. He has a keen interest with experience in Neuro-oncology, Epilepsy and Neuro-inflammatory conditions. He obtained his diploma in neuroradiology from the European Board of neuroradiology in 2018. He has an extensive background in general surgery and neurosurgery having completed a Masters in general surgery in 2002 and also his membership of the Royal college of surgeons of Edinburgh in 2016.

Prof. Adda Bounedjar

Head of Medical Oncology , CHU Blida | Algeria

Adda BOUNEDJAR is Chairman of Medical Oncology Department Anti Cancer Center BLIDA ALGERIA. He is Professor of Medical Oncology at Blida 1 University. He is President of Algerian Society of Training and Research in Oncology (SAFRO) And Vice president of Arab Medical Association against Cancer (AMAAC). He is member in MENA-NCCN steering committee and in ASCO Clinical Practice Guideline Advisory ,member of scientific committee ESMO GI and he is also member of several international research group and scientific societies ( ACHOG, ICRG, Saint Paul, AMCI, BGICC, ASCO, ESMO…).

Mr. Adel Eid

Charge Nurse , Tawam Hospital | United Arab Emirates

Adel Eid, has a Bachelor's degree in the science of nursing and works as a Charge nurse. He is n Oncology Nursing navigator at Tawam Hospital Oncology Center. Previously, he was the nursing clinical instructor at KFSH& RC, Clinical Nurse Coordinator of Pediatric BMT, Palliative Care KFSH&RC. He was the nurse manager and the establisher of the pediatric oncology at KFSH&RC

Dr. Aftab Ahmed Bhatti

Consultant Physician, Urology Clinic , Tawam Hospital | United Arab Emirates

Dr Aftab Ahmad Bhatti has recently joined Tawam Hospital as a Consultant Urological Surgeon, after working in the United Kingdom for more than 25 years. The main focus of his work is Urological Oncology, Minimally Invasive Robotic Surgery and Laparoscopic surgery. Dr Aftab A Bhatti graduated from the University of Punjab, Rawalpindi Medical College, Pakistan. He completed his higher urological training from the Northern Deanery, Newcastle upon Tyne, UK. Dr Aftab Bhatti has published over 40 peer reviewed publications and his area of research interest includes kidney and prostate cancer. the area of his interest includes active surveillance for the low risk prostate cancer, surgical anatomy of prostate, refinements to surgical techniques for robotic assisted radical prostatectomy and surgical outcomes of the high risk prostate cancer and prognostic markers for the kidney cancer.

Dr. Ahmed Elzein

Consultant Radiologist , Tawam Hospital | United Arab Emirates

Dr. Ahmed Elzein, MBBS, MRCS, FRCR UK, CCT in diagnostic and subspecialty interventional radiology, acquired his extensive training in diagnostic and interventional radiology at Oxford University Hospitals, UK. In 2023, Dr. Elzein joined Tawam Hospital UAE

Dr. Aisha Alsalami

Consultant Medical Oncology , Sheikh Shakhbout Medical City | United Arab Emirates

Dr. Aisha Alsalami, MD, B.Sc, is a Consultant Medical Oncologist at Sheikh Shakhbout Medical City (SSMC) in Abu Dhabi Dr. Aisha is an Emirati medical oncologist , She has more than a decade of experience in oncology. Before joining Sheikh Shakhbout Medical City, she was a consultant medical oncologist for 11 years at Sheikh Khalifa Medical City in Abu Dhabi. Dr. Aisha has a special interest in treatment of breast cancer, providing palliative care and addressing survivorship issues of cancer patients. She is a leading patient advocate, educator and coordinates the breast cancer survivors support group at SSMC.

Ms. Alaa Al Dib

Regional Operational Lead , Axios International | United Arab Emirates

Alaa graduated as a clinical pharmacist from Alexandria university with a real passion for healthcare field and the ability to develop and grow business within the health sector. Working as a Regional Operation Lead at Axios International, a global healthcare access company with 25 years of specialized experience developing practical and sustainable solutions to patient access challenges in emerging markets and developing countries. Located in Abu Dhabi, UAE, Alaa supports the implementation of healthcare access programs in the UAE , spreading awareness about Axios managed patient support programs to external stakeholders' physicians , hospitals ,allied healthcare professionals ,NGO’s and regulatory bodies . Also support in business development and excellence in healthcare sector.

Dr. Alaaeldin Shablak

Consultant Medical Oncologist , National Center for Cancer Care and Research | Qatar

Dr. Alaaeldin Shablak qualified in Medicine at Tishreen University, Syria before moving on to the UK to train as a general physician. He later trained as a Medical Oncologist at St. James’s Oncology Centre in Leeds before moving to the university hospital of Southampton to work as a consultant medical oncology where he stayed for 5 years before moving to Qatar. His subspecialty clinical interests include Colorectal, Upper GI and HBP cancers as well as Acute Oncology. He has a personal interest in academic medicine, particularly Cancer Immunotherapy. He completed an MSc in Immunology and PhD/MD in Cancer Immunotherapy from the Universities of Oxford and Manchester respectively. He has authored and co-authored a number of peer-reviewed journal publications and presented at National and International conferences. In late 2020, he moved to the State of Qatar where he is currently working as a Consultant Medical Oncologist at the National Center for Cancer Care and Research. In his current position, he is the lead medical oncologist for the upper GI cancers at the NCCCR and the oncology research group officer for NCCCR oncology fellowship program.

Dr. Aladdin Marraoui

Consultant and Chief of Medical Oncology , Gulf International Cancer Centre | United Arab Emirates

Dr. Marraoui is Consultant and Chief of Hematology/Oncology at Gulf International Cancer Center in Abu Dhabi and Clinical Professor at Gulf Medical University, UAE. He previously served as Chief of Hematology/Oncology at Mafraq Hospital for 14 years. He graduated from Faculty of Medicine at Aleppo University/Syria. He did his Internal Medicine residency at Christ Hospital and Medical Center in Chicago, and his Hematology/Oncology fellowship at the University of Colorado Health Science Center in Denver, Colorado. He is American Board Certified and recertified in Internal medicine in 1992, 2002 and 2012, in Medical Oncology in 1999,2009 and 2019 and in Hematology in 1999, 2009 and 2019. Dr. Maarraoui authored and co-authored several abstracts and articles on Breast Cancer, Colon Cancer, Thyroid Cancer, lung cancer and Lymphoma focusing on these diseases in UAE.

Dr. Aly Abdel Razek

Chairman and Executive Director , Gulf International Cancer Center | United Arab Emirates

Dr. Abdel Razek graduated from Cairo University. He completed his residency in 1976 at Washington University in St. Louis, Mo., USA. He is board certified in both Radiation Oncology and Pediatrics. He co-authored four text books in radiation oncology and contributed to many publications in oncology journals. He served on the national committee of the Southwest Oncology Group, Intergroup Ewings Sarcoma and National Wilms Tumor Committee. Dr. Abdel Razek is a Fellow of the American College of Radiation Oncology. He is president of Medical Resources International and Chairman and Executive Director of the Gulf International Cancer Center.

Dr. Amar Lal

Hematologist and Oncologist , Tawam Hospital | United Arab Emirates

Dr. Amar Lal graduated from Dow University in 1993. He underwent medicine residency and followed by oncology fellowship. He qualified triple diploma in medicine, family medicine and oncology from CPSP Pakistan. Then he got triple diplomas from Royal Colleges of Physicians Ireland and Glasgow in medicine and speciality certificates oncology royal college London. He also qualified ESMO Examination Board in oncology. He has been local and international speaker in hematology and oncology and has more than 40 publications. He joined Tawam hospital in 2007 and he continued to be an active part of CME/ Scientific Program Coordinator, Member of Pharmacy & Therapeutics Committee (PTC), Patient safety physician manager, Member of Medication Utilization Committee (MSSC).

Dr. Amina Alzwae

General Radiologist , SEHA | United Arab Emirates

Dr. Amina Alzwae is a diagnostic radiologist with special interest in women and breast imaging , MSc in Diagnostic Radiology, High Diploma of Breast Imaging , MD in Diagnostic radiology

Prof. Amit Bahl

Director of Oncology , Spire Healthcare | United Kingdom

Prof. Amit Bahl is a Consultant Clinical Oncologist at Bristol Cancer Institute, University Hospitals Bristol and Clinical Director of Spire Oncology Centre with a special interest in breast and urological cancers. He is the research lead for uro-oncology at Bristol Haematology and Oncology Centre. He has led and developed the prostate brachytherapy service at Bristol. Prof. Bahl is an internationally renowned expert on all aspects of prostate cancer treatment and can discuss the intricacies of the new modalities of treatment including IMRT, proton therapy, single modality HDR brachytherapy, enabling patients to come to an informed decision. He has been an expert adviser to NICE for the technology appraisal on new drugs and an external service reviewer at oncology departments elsewhere in the country.

Dr. Anwar Al Nouri

Oncologist , Kuwait Cancer Control Centre | Kuwait

Dr. Anwar Al Nouri is a Consultant Medical Oncologist at Kuwait Cancer Control Centre (KCCC). He has done Clinical Research in Medical Oncology Fellowship (Breast) from McGill University. He is the Associate Member of the American Society of Clinical Oncology, Fellow of the Royal College of Physicians & Surgeons of Canada. He has the Canadian Board in Internal Medicine (FRCPC).

Ms. Aqeela Sheikh

Palliative Care Specialist Nurse , Burjeel Medical City | United Arab Emirates

Nurse Aqeela Sheikh is a Palliative Care Nurse Specialist and Palliative Care Nurse Manager in Burjeel Medical City

Dr. Arif Raza Alam

Chief of Hematology , Tawam Hospital | United Arab Emirates

Chief of Hematology – Tawam Hospital

Dr. Aser Farghal

Consultant Interventional Radiologist , Tawam Hospital | United Arab Emirates

Dr Farghal is a c Interventional and Diagnostic Radiologist at Tawam Hospital. He has completed his training in diagnostic and interventional radiology at the East of England Radiology training programme in the UK. He then did a fellowship in Vascular and Interventional Radiology at McGill University in Canada. He was appointed as a Consultant Interventional Radiologist at the Norfolk and Norwich University Hospitals and Honorary lecturer at the Norwich School of Medicine in 2012. Dr Farghal moved to the UAE in 2017. His main interest is Vascular and Non vascular intervention . He is currently leading the Urology MDT at Tawam hospital.

Dr. Ashraf Farrag

Consultant of Radiation Oncology , Prince Sultan Military Medical City | Saudi Arabia

Dr. Ashraf Farrag is a Consultant of Radiation oncology at Prince Sultan Military Medical City (PSMMC) - Riyadh- KSA and a Professor of Clinical Oncolgy - Assiut University- Egypt. He has a Doctoral Degree in Clinical Oncology, Assiut University and PhD in Radiation Oncology from the Free University of Brussels (VUB) - Brussels - Belgium.

Dr. Asif Quadri

Consultant Anatomical and Cyto-pathologist , NRL | United Arab Emirates

Dr. Asif Quadri is a Consultant Anatomical and Cyto-pathologist, who joined NRL, after working as Consultant and Chief of Anatomical Pathology at Tawam Hospital, the Regional Cancer Centre in UAE for seven years. Prior to that, he worked as a Consultant Anatomical Pathologist for five years at City Hospital, Sandwell & West Birmingham NHS Trust, UK. Dr. Quadri’s special interests include biomarkers, gynecological pathology, breast pathology, lung tumors, genitourinary pathology, and soft tissue tumors. After completing his medical degree at the College of Medicine, the University of Baghdad in Iraq. Dr. Quadri pursued his pathology residency training in the UK. He was awarded a Certificate of Completion in Specialist Training (CCT) for Anatomical Pathology & Cytopathology from the Postgraduate Medical and Education Training Board and General Medical Council in the UK and a Fellow of the Royal College of Pathologists, London. His interest in Medical Education earned him a Postgraduate Certificate in Medical Education from the University of Staffordshire, also in the UK. Dr. Quadri is a College of American Pathologists (CAP) accreditation inspection team member. He is also a regional expert and trainer for companion diagnostic immunochemistry for PDL1 biomarker clones. He has been published in numerous professional journals and frequently presents cases and papers at local and regional meetings.

Dr. Asma Al Olama

Consultant Hematologist Onologist , Dubai Hospital | United Arab Emirates

Dr. Asma Al Olama is a Consultant Haematologist Oncologist, DAHC, Head of Haemtology Department Dubai Hospital and President of the Emirates Society of Haematology

Mrs. Asma Nasser Alblooshi

Charge Nurse , Tawam Hospital | United Arab Emirates

Ms. Asma Nasser Alblooshi is a nurse manger at Tawam Hospital , with a wide range of expertise in the hematology , oncology and palliative care . She is the ENOS vice president and ENA member, moderator in international medical conferences and speaker, instructor in oncology Educational program and member of oncology Nursing advisory group .

Dr. Atif Iqbal

Associate Professor and Chief, Section of Colorectal Surgery , Baylor College of Medicine | United Arab Emirates

Dr. Atif Iqbal earned his medical degree from King Edward Medical University and completed a surgical internship at Mayo Hospital, Pakistan. He then completed a surgical research fellowship at Creighton University Medical Center in Omaha, Nebraska, followed by a general surgery residency at the University of Missouri and a colon and rectal surgery fellowship at Washington University/Barnes-Jewish Hospital in St. Louis. He joined the University of Florida (UF) as an assistant professor in 2011 and was promoted to associate professor in 2018. Dr. Iqbal leads the Colorectal Surgery team, and specializes in surgical procedures for benign and malignant pathology of the colon, rectum and anus. He has a special interest in advanced laparoscopic and robotic surgical procedures for colon and rectal cancer, including sphincter saving procedures for low rectal cancer. He is a member of the Baylor Inflammatory Bowel Disease Center and offers laparoscopic pouch procedures for ulcerative colitis and minimally invasive surgery for Crohn’s disease.

Dr. Atlal Abusanad

Associate Professor , King Abdulaziz University Hospital | Saudi Arabia

Atlal Abusanad, MBBS, MSc, ABIM, FRCPC, CIP, is a medical oncologist and associate professor, Faculty of Medicine, King Abdulaziz University and Hospital, Jeddah, Saudi Arabia. Dr. Abusanad completed medical oncology and a Clinician-investigator fellowships from McGill University, focused on breast oncology along with a MSc in experimental medicine of molecular oncology. She is a recipient of a national prize for innovative approach in supporting breast cancer survivors. She has been recognized by ASCO for 2 consecutive years as one of the authors of the best of ASCO connections blogs. She led the largest multinational study addressing burnout in oncology professionals across MENA. Her scientific research include clinical breast cancer, molecular oncology, cancer survivorship, oncologist’s wellbeing and narrative medicine. She is a volunteer in several breast cancer social and patient’s advocacy forms and a speaker at TED talks.

Dr. Aydah Al Awadhi

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr. Aydah Al Awadhi is a Consultant Physician, Oncology Clinic at Tawam Hospital

Dr. Bassel Jallad

Staff Physician , Cleveland Clinic Abu Dhabi | United Arab Emirates

Bassel Jallad, MD, CPE is a Staff Physician at Cleveland Clinic Abu Dhabi and Adjunct Assistant Professor, School of Medicine, at St. Louis University, St Louis, Missouri, USA. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Jallad was the Associate Director of Medical Oncology Fellowship Program at St Louis University in St Louis, Missouri and the Medical Director of Medical Oncology Service Line at Blessing Health System in Quincy, Illinois, USA. Dr. Jallad received his medical degree from Jordan University of Science and Technology, Irbid, Jordan, and completed his residency at the University of Illinois, Chicago, USA. He completed his fellowship at the Henry Ford Hospital, Wayne State University, Michigan, USA. Dr. Jallad is triple American Board Certified in Internal Medicine , Medical Oncology and Hematology. Dr. Jallad is a Certified Physician Executive (CPE), earned his degree in 2020 from American Association For Physican Leadership (AAPL) - USA, and currently an active member of the AAPL society. Throughout his tenure, Dr. Jallad has specialized in managing different cancer types, especially Breast Cancer, and the management of benign and malignant hematological disorders. Dr. Jallad has multiple peer reviewed publications discussing various cancer related topics in highly influential medical journals.

Dr. Bassim Al Bahrani

Consultant Medical Oncologist , Gulf International Cancer Centre | United Arab Emirates

Dr. Bassim Al Bahrani, is a renowned Medical oncology in the Sultanate of Oman who was the previous Director of National oncology center. He has a vast experience in the field for over 25 years. Part time Consultant Medical Oncologist and chief operating officer at the Gulf International Cancer Center. Working as Senior Consultant Medical Oncologist, Royal Hospital Muscat, Oman, and a visiting Professor at the Postgraduate Program on Health Economics, Management and Policy at the University of Peloponnese in Corinth, Greece. Worked as the Director of the National Oncology Center, Oman, Royal Hospital Oman for 9 years until December 2018. Done his advanced training in Medical Oncology in Australia and earned a fellowship from the Royal Australasian College of Physicians. He is an honorary Fellow of the Royal College of physicians and surgeons of Glasgow and Ph.D. from the University of Rome Tor Vergata. Chairman of the Ministry of Health Oman, and Royal Hospital Scientific and Research Committee, and deputy Chairman, Royal Hospital, Oman Scientific and Research Committee. Member of many Oncology associations, including the European Society of Medical Oncology, American Society of Clinical Oncology, Gulf Federation for Cancer Control, and Medical Oncology group of Australia.

Dr. Benjamin Musher

Associate Professor , Baylor College of Medicine | USA

Dr. Benjamin Musher is the Medical Director of Medical Oncology at Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center. A Medical Oncologist specializing in gastrointestinal cancer, Dr. Musher is also an Associate Professor and the Director of DLDCCC’s Gastrointestinal Cancer Program. He holds the Barry Smith Endowed Professorship at BCM. As an educator, Dr. Musher has received numerous accolades including Oncology Faculty Educator of the Year for six consecutive years and the Fulbright & Jaworski L.L.P. Faculty Excellence Award, which recognizes BCM faculty for excellence in teaching and evaluation. He has also been recognized with several awards for going above and beyond to deliver exceptional patient experiences; and in 2016 was named a Top Doctor by Houstonia Magazine. Dr. Musher came to BCM in 2009 from the University of Pennsylvania, where he spent the previous five years as an attending physician and fellow in the Division of Hematology- Oncology. Dr. Musher completed his residency in internal medicine at the University of Washington’s Department of Medicine, where he was also an attending physician from 2003-2004. A graduate of St. John’s School in Houston, he earned an AB in Social Studies from Harvard University and received his MD with Honors from BCM.

Ms. Camille Barcebal

Senior Infection Prevention and Control Officer , SEHA – Al Ain Region | United Arab Emirates

Camille Barcebal - Beltran is a registered nurse by profession, who is currently one of the Senior Infection Prevention and Control officers of SEHA Al Ain region, covering patient care areas such as NICU, Pediatrics, Endoscopy and Oncology Wards. She is the Infection Control lead of the Hospital Wide CLABSI Taskforce of Tawam Hospital. She graduated Bachelor of Science in Nursing at the University of Santo Tomas in the Philippines on 2005 and currently on her Master of Arts degree in Nursing at Wesleyan University – Philippines ; She has practiced her profession in Medical, Surgical and Pediatrics for 11 years in Philippines, K.S.A and U.A.E. She has more than 5 years of experience in Infection Prevention and Control and has received her certification from the Certification Board of Infection Control and Epidemiology (CBIC).

Dr. Caroline Diorio

Pediatric Oncologist , Children’s Hospital of Philadelphia | USA

Dr. Caroline Diorio is a pediatric hematologist-oncologist at the Children’s Hospital of Philadelphia with a clinical focus on pediatric leukemias and the application of cellular immunotherapies, such as chimeric antigen receptor T-cells (CART) for children with difficult to treat leukemias. Her research focus is on translating immunotherapies for childhood T-cell acute lymphoblastic leukemia (T-ALL) from the laboratory into the clinic, and on mechanistic understanding of the side effects of CART, including cytokine release syndrome (CRS) and immune effector cell associated neurotoxicity syndrome (ICANS). Dr. Diorio completed her medical school at the University of Toronto and pediatric residency at McMaster Children’s Hospital. She then completed a pediatric hematology-oncology fellowship at the Children’s Hospital of Philadelphia. During fellowship, she completed a Master of Science in Translational Research at the University of Pennsylvania.

Dr. Cherian Thampy

Consultant Medical Oncologist , NMC Hospital | United Arab Emirates

Dr. Cherian is a medical oncologist at NMC with 8 years’ experience in Oncology from the prestigious KIMS - Cancer Center in Trivandrum, India where he was working as Associate Consultant in Medical Oncology since 2015. Prior to KIMS, Dr. Cherian was working at the world renowned Cancer Institute, Chennai, India as an Assistant Professor of Medical Oncology. Dr. Cherian Thampy key areas of interest are: Gastrointestinal Oncology, Lymphomas, Breast Cancers and Immunotherapy He has also worked at SRMC, Chennai, India and Lakeshore Hospital, Kochi, India. Dr. Cherian Thampy completed MBBS from K.S. Hegde Medical Academy, Mangalore and thereafter obtained his MD in General Medicine from Sri Ramachandra Medical College, Chennai. He went on to complete his DM in Medical Oncology from The Cancer Institute, Chennai, India. Dr. Cherian Thampy successfully completed his MRCP Speciality certification in medical oncology. It is certified by the federation of royal college of physicians of United Kingdom and the association of cancer physicians.

Dr. Colin Maciver

Consultant Head & Neck Surgeon , Sheikh Shakbout Medical City | United Arab Emirates

Dr Colin MacIver Consultant Maxillofacial /Head & Neck Surgeon MBChB BDS FDS FRCS FRCS Ed FRCS (OMFS) MBA Consultant Maxillofacial / Head and Neck Surgeon at SSMC, Abu Dhabi. Adjunct Professor of Surgery at Khalifa University, Abu Dhabi Graduated in Medicine and Dentistry from Manchester in the UK. Completed surgical training in the UK. After finishing training, he completed a fellowship in microvascular surgery and facial transplant in Paris, France. Previously consultant Maxillofacial / Head and Neck surgeon at the regional Maxillofacial Unit in Glasgow, UK. Became Clinical Director of the regional unit in Glasgow in 2014 before moving to Abu Dhabi in 2018. He is currently a head and neck microvascular surgeon and vice chair of surgery at SSMC. He is adjunct professor of surgery at Khalifa University and medical school. Dr Maciver’s current areas of clinical practice are Head and Neck cancer, Reconstructive surgery including microvascular free tissue reconstruction, Thyroid and parathyroid surgery, Saliva gland surgery and craniofacial trauma.

Dr. Crystal Denlinger

Chief Executive Officer , National Comprehensive Cancer Network (NCCN) | USA

Crystal Denlinger is the Chief Executive Officer of the National Comprehensive Cancer Network® (NCCN®), having joined NCCN as Senior Vice President, Chief Scientific Officer in April 2021. Dr. Denlinger has a long history of global cancer leadership with NCCN and beyond. She was named an NCCN Young Investigator Awardee in 2012 and receive the NCCN Rodger Winn Award in 2018 for exemplifying leadership, drive, and commitment in service to developing NCCN Clinical Practice Guidelines in Oncology. Before being named Chief Scientific Officer, she was chair of the NCCN Guidelines Panel for Survivorship and served as a member of the Bone Cancers, Esophageal/Gastric Cancers, and Occult Primary Cancers panels, as well as the panel for Older Adult Oncology. She has also participated on the editorial board of the JNCCN—Journal of the National Comprehensive Cancer Network, numerous abstract and scientific review committees, and in NCCN’s work on the NCCN Harmonized Guidelines for Sub-Saharan Africa. Prior to joining NCCN, Dr. Denlinger was an Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, an NCCN Member Institution. At Fox Chase, she served as the Chief of Gastrointestinal Medical Oncology, Deputy Director of the Early Phase Drug Development Program, and Director of the Survivorship Program. Her expertise is in clinical trials, survivorship care, and gastrointestinal malignancies. She is a practicing medical oncologist, maintaining a limited clinical practice at Fox Chase Cancer Center in Philadelphia, PA after over a decade of clinical practice prior to joining NCCN. Dr. Denlinger is a graduate of the combined BS/MD program at The College of New Jersey and Rutgers New Jersey Medical School. She completed her internal medicine residency at Mount Sinai Medical Center in New York City and her fellowship in hematology/oncology at Fox Chase Cancer Center/Temple University Hospital in Philadelphia. She is board certified in Internal Medicine and Medical Oncology. Dr. Denlinger is a Fellow of the American College of Physicians (ACP) and a member of several medical societies, including the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO).

Prof. Daniel Palmer

Professor and Honorary Consultant in Medical Oncology , University of Liverpool | United Kingdom

Professor Palmer took his current position of North West Cancer Research Chair in Medical Oncology at the University of Liverpool in 2011. His research interests relate to HPB cancers (liver, pancreas and biliary tract) and incorporate basic laboratory science, translational research and clinical trials. His laboratory research is currently investigating novel therapeutic approaches to the treatment of HPB cancer through stimulation of anti-tumour immune responses and targeting tumour micro-environment including the tumour microbiome, and developing and validating biomarkers for a stratified approach to treatment. He is a member of the UK NCRN Upper GI cancers clinical studies group, and the hepatobiliary and pancreatic sub-groups. He is Director of the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre and has established a portfolio of early phase clinical trials and translational studies and he is Chief Investigator for the TACE-3 and RaTIO trials investigating immunotherapy combinations for patients with intermediate and advanced HCC respectively.

Dr. Darakhshan Kanwal

Specialist Radiologist , Tawam Hospital | United Arab Emirates

Dr Darakhshan Kanwal is a Specialist Radiologist working in Diagnostic Imaging and Breast Care Centre. She completed her Bachelors in Medicine and Surgery (MBBS) and Post Graduate Degree in Radiology (FCPS) from Aga Khan University Hospital, Pakistan. She was also awarded the European Diploma in Radiology (EDIR). She has been working in UAE for almost 10 years as Diagnostic Radiologist with special interest in Breast/women, Pediatric imaging and was part of National breast cancer Screening program in Northern Emirates. She has various research publications in renowned journals and remains active member of various societies related to Radiology.

Dr. David Chang

Professor of Surgical Oncology , University of Glasgow | United Kingdom

David is a surgeon scientist who specialises in the treatment of malignant pancreatic diseases. His research focus is on the development and implementation of novel therapeutic strategies for pancreatic cancer, particularly around DNA-damage response deficiency, by utilising molecular biomarkers of prognosis and therapeutic responsiveness. David undertook his pancreatic surgical fellowship, PhD, and post-doctoral training in Australia. In 2013 he was recruited to University of Glasgow along with Prof Andrew Biankin, as part of an initiative to implement precision medicine in West of Scotland and the UK. David co-leads Precision-Panc, a pan-UK initiative to deliver personalised cancer care for pancreatic cancer, and is the chief investigator of its Master Protocol and the first inter-related clinical trials. He is also involved in the Precision Promise initiative, a Pancreatic Cancer Action Network (USA) initiative dedicated in delivering personalized treatment for patients with pancreatic cancer, and contributes to ICGC ARGO, aiming to shape the future of the next generation cancer genomic projects to ultimately realise the goals and promises of precision medicine. Clinically, David is an Honorary Consultant Pancreatic Surgeon at Glasgow Royal Infirmary as part of the West of Scotland Pancreatic Unit that serves as tertiary pancreatic referral centre for the West of Scotland. His research aims to shorten the distance between the bench and the clinic to ensure meaningful and seamless translation between the two.

Prof. David Kerr

Professor of Cancer Medicine , University of Oxford | United Kingdom

Professor David Kerr CBE MA MSc MD PhD DSc FRCP (Glasgow), FRCP (Edinburgh) FRCP (London) FRCGP (Hon) FACP FESMO FMedSci. David contributes to Oxford as Professor of Cancer Medicine, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital. He is an Honorary Professor of Oncology in Sichuan, Suchow, Xiamen, Zhejiang, Shanghai, Oslo and Seoul National Universities. He has an international reputation for the treatment of and research into cancer (ranked in top 1-2% globally) and the quality of his work has been recognised by the award of several national & international prizes, including the Harvard Global Health Catalyst: Distinguished Leader Award, in recognition of his many years of leadership in global health work. He has served as health adviser to two British Prime Ministers and has supported National Cancer planning in the UK, Sub Saharan Africa (Ghana, Nigeria and Kenya), India, Iraq and is a Trustee of the AMAR Foundation, delivering primary healthcare in refugee camps.

Dr. Deepthi Vilasini/Silymon

Medical Oncologist , Sheikh Shakhbout Medical City | United Arab Emirates

Dr.Deepthi Vilasini/Silymon is a Medical Oncologist with nearly 14 years of experience in Oncology post Residency. She has completed her residency in Oncology from India following which she obtained MRCP Medical Oncology certification by Royal college of physicians, UK and received ESMO certification in Medical Oncology ranking within top 20 percent worldwide . She has extensive experience dealing with all solid tumors and also in teaching undergraduate and post graduate medical students . She is currently working in SSMC /Mayo UAE as Staff Medical Oncology physician and is also the Quality and Patient Safety Chair of Oncology in SSMC. She has worked as Consultant Medical Oncologist in number of hospitals in different countries including India,Bahrain and UAE before joining SSMC

Prof. Derek Tsang

Assoc. Prof.- Dept. of Radiation Oncology , University of Toronto | Canada

Dr. Derek Tsang is an Associate Professor in the Department of Radiation Oncology at the University of Toronto. He is a radiation oncologist at the Princess Margaret Cancer Centre and Hospital for Sick Children in Toronto, Canada. He completed his medical training at Queen’s University, followed by residency at the University of Toronto. He obtained fellowship training at St. Jude Children’s Research Hospital in Memphis, Tennessee, and holds a Masters’ degree in clinical epidemiology from the Harvard T.H. Chan School of Public Health. Dr. Tsang’s research interests include evaluating re-irradiation for recurrent tumours and reducing the late effects of radiotherapy. He participates in international cooperative group studies with the Children’s Oncology Group and NRG Oncology, serves as an Associate Editor for the Red Journal and sits on the Editorial Board for Neuro-Oncology. He joined the Princess Margaret Cancer Centre in 2017 and is a member of the adult Central Nervous System (CNS) and Eye tumour site groups, and leads the Paediatric Radiation Therapy Program. His clinical practice includes adult neuro-oncology, paediatric oncology, and stereotactic radiosurgery for intracranial neoplasms.

Dr. Diaeddine Trad

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Dina Hamza

Consultant Medical Oncologist , Dubai Health Authority | United Arab Emirates

Consultant medical oncology Completed training in Oncology 2001 National Cancer Institute - Masters degree in clinical Oncology Cairo University - Fellowship from ULM university Germany - European Board certified from European school of Oncology worked in different health care systems Working in Dubai since 2008 Had more than 20 publications in oncology the most citation was for the MENA Breast Guidelines; acknowledged by e-cancer search foundation Member of the most dynamic, scientific and leading organization; EOS

Dr. Dragana Milojkovic

Consultant Haematologist , Hammersmith Hospital | United Kingdom

Dragana Milojkovic is a consultant haematologist at Hammersmith Hospital with a focus on myeloid malignancies, in particular chronic myeloid leukaemia, myeloproliferative disordersdisorders, and transplantation. Prof Milojkovic is also an honorary senior lecturer in haematology for Imperial College, London with post graduate teaching and research commitments. Prof Milojkovic is the director of the clinical trials unit at Hammersmith Hospital and is actively involved in the clinical trials for chronic myeloid leukaemia (CML) and myeloproliferative disorders (MPD) which are currently in place which include tyrosine kinase inhibitor therapy for newly diagnosed and resistant patients, strategies to tackle MRD in CML and novel agents in MPD. She is a member of national and European working parties including those in CML, MPD and the European Society for Blood and Marrow Transplantation Chronic Malignancy.

Dr. Edward Black

Consultant - Thoracic Surgery , SEHA | United Arab Emirates

Dr Edward Black graduated from Guy’s Medical School, London in 1992. He trained in Cardiothoracic Surgery in Oxford, Leicester, Nottingham, Sheffield and Edinburgh. He was awarded Certificate of Completion of Specialist Training in Cardiothoracic Surgery in 2005. He is a Fellow of the Royal College of Surgeons of England in General Surgery and Cardiothoracic Surgery. He was appointed Consultant Thoracic Surgeon in Nottingham University Hospitals in 2006, Oxford University Hospitals in 2009 and SEHA in 2014. He currently works in SEHA-Mayo Clinic joint venture at SSMC Abu Dhabi and is Associate Professor at Khalifa University Medical School Abu Dhabi. He is Vice President of the Thoracic Surgery Group of the Emirates Respiratory Society.

Ms. Elaine Westraadt

Radiation Therapist , Tawam Hospital | United Arab Emirates

Elaine Westraadt holds dual qualification in the field of Radiography. Qualified as Diagnostic Radiographer in 1994 at the Central University of Technology in South Africa, she was one of the first diagnostic radiographers in South Arica to have her own private practice in Gauteng. With her passion for oncology care, she achieved her second qualification as Therapeutic Radiation Therapist in 2005 from the Cape Peninsula University of Technology in Cape Town, South Africa. Since 2022 she has been employed as Radiation Therapist at the larges Oncology Centre in the UAE, Tawam Hospital. Elaine believes that patient care is the backbone of Oncology treatment and contributes a large part of the overall wellness of the oncology patient. She feels that in a radiotherapy department where the staff feels appreciated and valued, their creativity will blossom, and this will directly translates to the patients’ wellness and care. Her passion for psychology and philosophy gave her a keen interest in palliative care and paediatric radiotherapy.

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Emad Tashkandi

Associate Professor , Umm AlQura University | Saudi Arabia

Dr. Tashkandi completed his medical degree from Umm Al-Qura University (UQU) in Makkah, Saudi Arabia. He completed Internal Medicine Residency Training Program at University of Western Ontario (UWO) in 2013 and Medical Oncology Fellowship Training at McMaster University in 2015, Canada. He also completed Clinical and Research Fellowship in GU & GI Malignancies along with Graduate Diploma of Clinical Epidemiology (GDCE) in 2016 at McMaster University, Canada. He was appointed as an Assistant Professor in the Department of Internal Medicine at UQU in 2017 and Medical oncologist in Oncology Center at King Abdullah Medical City (KAMC) in Makkah, Saudi Arabia.

Dr. Erik Koornneef

Director of Research and Innovation , Pure Health | United Arab Emirates

Dr Erik Koornneef is a global healthcare executive with 25 years of international management experience in growing healthcare economies. He currently is currently the Director of Research and Innovation with Pure Health, the largest, integrated healthcare platform in the United Arab Emirates. Previously Erik has held multiple senior roles in the healthcare industry, including the Health and Information Quality Authority of Ireland, the Abu Dhabi Department of Health, the Abu Dhabi Health Information Exchange, the UAE Ministry of Presidential Affairs and Truven Health Analytics / IBM Watson Health. Erik holds a PhD in Health Policy and Management, Erasmus University Rotterdam, the Netherlands. He also holds a M.Sc. In Health Services Management, Trinity College Dublin, Ireland and M.Sc. in Educational Sciences from the Radboud University of Nijmegen, the Netherlands Erik has served as an expert advisor for a variety of international organisation such as the Council of Europe, European Partnership for Supervisory Organisations (EPSO) and the Institute for Healthcare Improvement (IHI).

Dr. Erminia Albanese

Consultant Neurosurgeon , University Hospitals of North Midlands | United Kingdom

"I studied Medicine and completed the training in Neurosurgery in Italy (equivalent to the M.B. Ch.B. and the FRCS). In 2009 I completed a research Fellowship in microneurosurgical anatomy at Mercer University, Georgia, USA. In 2011 I moved to King’s College Hospital in London where I performed a Fellowship in Surgical Neurooncology. I have a special clinical interest in the surgical treatment of benign and malignant brain tumours. I provide advanced neurosurgical techniques including intraoperative neurophysiological monitoring and mapping during both asleep and awake craniotomies; moreover, I perform fluorescence-guided surgery. I am a member of the Genomic tumour advisory board at the West Midlands Genomic Medicine Centre in Birmingham. I introduced Genomic Medicine at UHNM. I am actively involved in training both undergraduate students from Keele University and postgraduate trainees. I sit on the Surgical Training Committee for neurosurgical trainees for Health Education England West Midlands."

Dr. Ernest Johan Luiten

Chief of Breast Cancer Center , Tawam Hospital | United Arab Emirates

Chief of Breast Cancer Center- Tawam Hospital

Dr. Esam Murshid

Consultant Medical Oncologist , Prince Sultan Medical Military City | Saudi Arabia

Consultant Medical Oncologist and Director Oncology Center Prince Sultan Medical Military City Riyadh Kingdom of Saudi Arabia Fellow of the Royal College of Radiologist, Faculty of Clinical Oncology, London Uk Cofounder and past president of the Saudi Oncology Society SOS Member of the of The Saudi National Oncology institute Advisory Board Member of the Saudi Cancer Registry Board Chairman of the Ministry of Defense Health Services Department Oncology Services Permanent Supervisory Committee. Reviewer for the National Commission for Academic Accreditation and Assessment (NCAAA). Past Chairman of the medical advisory committee for total quality management and patient safety at PSMMC. Co-founder of the saudi board of medical oncology under the saudi commission of health specialties amd member of the 1st training board. Founding member of many charitable cancer societies. Co-founder of the national breast cancer screening program under the ministry of health and chairman of the Scientific advisory committee. Member of the national executive cancer control committee under the saudi council of health. Past Consultant and advisor at saudi commission health specialties and member of the scientific societies board . Past Director and lecturer for the MOH cancer training program for primary care physicians courses and senior consultant for MOH cancer control program.

Dr. Fahad Ibnshamsah

Chairman of Adult Medical Oncology department , King Fahad Specialist Hospital | Saudi Arabia

Dr Fahad Ibnshamsah is a consultant in Medical Oncology. He is the Chairman of the Adult Medical Oncology Department, Oncology Centre, King Fahad Specialist Hospital in Damam. He is also the Director of Outreach Program in King Fahad Specialist Hospital and Assistant Professor of Internal Medicine at Imam Abdulrahman Bin Faisal University.

Dr. Fahed Abdullah

Paediatric Oncologist , Burjeel Medical City | United Arab Emirates

Dr. Mohammad Fahed Abdullah, Consultant, pediatric Hematologist/Oncologist at Burjeel Medical City (BMC), Abu Dhabi. Dr Fahed obtained his medical degree from university of Aleppo Syria after which he did his training in Pediatrics and fellowship in Pediatric Hematology/Oncology at State University of New York, USA. He is American board certified in both pediatrics and Pediatric Hematology/Oncology and he has more than 30 year-experience in this field during which he worked in many major hospitals in USA and in the region including Sheikh Khalifa Medical City in Abu Dhabi before joining BMC.He has tremendous experience in managing a variety of childhood blood and oncologic disorders including rare diseases with special interest in Leukemia, lymphoma, brain tumors, bleeding, and coagulation disorders in addition to vascular anomalies. Dr Abdullah is member in many international medical societies such as American Society of Hematology and European Hematology Association and he has given numerous local, regional, and international presentations and participated in many scientific committees, including serving as the cochairman of the organizing committees. He has done many research and publications in the field of pediatric hematology/oncology.

Dr. Faisal Azam

Consultant Medical Oncologist , King Fahad Specialist Hospital | Saudi Arabia

Dr Faisal Azam is a consultant medical oncologist at King Fahad specialist Hospital Dammam (KFSHD) and previously worked as a consultant at Betsi cadwaladr university board Hospital in United Kingdom. He has special interest in GU cancers, Gynae cancers, sarcomas and skin cancers. He had completed a formal training in Medical oncology at Clatterbridge cancer centre, Liverpool leading to a CCT and a research training at Oxford University. His qualifications include FRCP, CCT in medical oncology, MRCP-UK, MRCP-Ireland, PG-Dip in Oncology from Birmingham University and PG-Cert in Medical education from Edgehill Liverpool University. He is currently a research in-charge for Oncology, an IRB (Investigational review board) member and FTC (Formulary therapeutics committee) member at KFSHD. He has published more than 40 articles in peer-reviewed journals and did presentations in many international, national and regional oncology conferences.

Dr. Faisal Al Terkait

Medical Oncologist , Kuwait Cancer Control Center | Kuwait

Dr. Faisal Alterkait is a Medical Oncologist in Kuwait Cancer Control Center from 2012, Head of breast unit from 2017 to 2021, and inaugurated the first medical oncology departments outside KCCC in Kuwait. Currently he is the Head of Medical Oncology Department at Jaber Al-Ahmad Hospital in Kuwait.

Dr. Faraz Khan

Consultant Hematologist , American Hospital | United Arab Emirates

Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 19 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He is Chief of Internal medicine and Head of Hematology program and working as a Consultant Hematologist and Medical Oncologist at American Hospital Dubai.

Dr. Farooq Latif

Consultant Medical Oncologist , Dubai Hospital | United Arab Emirates

Dr Farooq Latif is currently working as a consultant medical oncologist in Dubai Hospital. After graduation, Dr Farooq completed general internal medicine training in North Yorkshire, UK and attained MRCP in 2007. He then completed clinical oncology training in Liverpool, Merseyside leading to CCT. Dr Farooq became a fellow of Royal college of radiologist (FRCR), faculty of clinical oncology in 2013 and was subsequently awarded fellowship of Royal college of Physicians of Glasgow FRCP (Glasg) and fellowship of Royal college of physicians of Edinburgh FRCP(Edin). He worked as a consultant clinical oncologist in North Wales cancer centre and Royal stoke university hospital, Midlands, UK. He has keen interest in teaching and research and has published in peer-reviewed journals.

Dr. Fathi Azribi

Consultant Medical Oncologist , American Hospital Dubai | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Fieke Froeling

Clinical Senior Lecturer , University of Glasgow | United Kingdom

Fieke Froeling, MD, PhD, MRCP, is a Clinical Senior Lecturer at the University of Glasgow and an Honorary Consultant Medical Oncologist at the Beatson West of Scotland Cancer Centre.

Ms. Fiona Watson

Chief Quality Officer , Tawam Hospital | United Arab Emirates

Fiona is Chief Quality Officer, Al Ain Region, SEHA - she has extensive health care experience in clinical practice, quality improvement, senior leadership and governance. Fiona is originally from Scotland where she worked in the NHS and the Scottish Health Department before moving to Victoria, Australia where she worked for 12 years. During this time she had senior roles in the Victorian Department of Health and healthcare facilities, including being the executive lead for clinical governance and community engagement at Melbourne Health, prior to her move to the UAE and commencing her role with SEHA in 2021. During her time in Melbourne, Fiona worked for 5 years as Executive Director Quality and Patient Experience at Peter McCallum Cancer Centre, where she led, and was passionate about, ensuring the delivery of high quality cancer services, improving patient experience and access to cancer treatment, particularly for Indigenous Australians. She led the development of the first Cancer Care Pathway for Aboriginal patients. This work had significant impact on Aboriginal health, patient experience and engagement with the community.

Dr. Francois-Guirec Champoiseau

CEO and Co-Founder , Cureety | France

Francois-Guirec Champoiseau is a serial entrepreneur who started his first company at the age of 19 in the automotive industry. After 3 years, Francois was appointed the interim CEO of a distressed tech start-up to oversee its restructuring for a year. Prior to launching Cureety, Francois worked as an M&A banker in healthcare to advise health-tech start-ups on fundraising and M&A activities. In 2018, Francois co-founded Cureety to improve the care offering for cancer patients worldwide. Cureety is the first oncology Software as a Medical Device company to obtain reimbursement status through statutory insurance in France due to the benefits provided by the technology to patients, healthcare providers and health systems. Francois received his master’s degree from Grenoble Ecole de Management in 2014.

Dr. Giannis Mountzios

Consultant Medical Oncologist , Air Force General Hospital | Greece

Dr Giannis Mountzios (MD, MSc, PhD) was born in Larissa, Greece, in 1974. He obtained his Medical Degree (MD) from the Aristotle University of Thessaloniki in 1998 with a scholarship from the Greek Ministry of Education and graduated from the Hellenic Military Medical Academy the same year. He completed his residency in Internal Medicine at the 251 Air force General Hospital of Athens and in Medical Oncology at the University of Athens School of Medicine, “Alexandra” University Hospital. In 2010 he obtained his PhD in Medical Oncology from the University of Athens School of Medicine. Dr Mountzios is currently working as a consultant Medical Oncologist at the Department of Medical Oncology in the Air force General Hospital in Athens. Dr Mountzios has received fellowships from the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and the Hellenic Society for Medical Oncology (HESMO). He is a member of the Board of Directors of HESMO and previous chair of the HESMO young medical oncologists committee. From 2012 to 2014, Dr Mountzios was a member of the ESMO Young Oncologists Committee. Since 2019, he is a member of the ESMO Educational Publications Working Group

Dr. Gokul Sathyarathnam

Consultant Medical Oncologist , NMC Royal Hospital | United Arab Emirates

Dr Gokul Sathyarathnam is a Consultant Medical Oncologist who specializes in the treatment of adult solid malignancies with chemotherapy, immunotherapy, targeted therapy and hormonal therapy. He treats adult patients (age 18 and above) and his areas of interest include Lung cancer, Breast cancer, Gastrointestinal cancers, Hepatobiliary cancers, Gynecological cancers and Genitourinary cancers. Dr. Gokul did his MBBS from Trivandrum Medical College, University of Kerala in India. After his MRCP from UK, he completed his Medical Oncology training from Northern Centre for Cancer Care in Newcastle upon Tyne, UK. He also completed the Certificate of Completion of Specialist Training (CCST) in Medical Oncology from UK. Dr. Gokul worked as a Consultant Medical Oncologist in James Cook University Hospital in Middlesbrough, UK and later joined SEHA in 2009 and worked as a Consultant in Medical Oncology at Sheikh Khalifa Medical City (SKMC) and later in Sheikh Shakbout Medical City (SSMC). Dr Gokul is fluent in English and Malayalam and has a working knowledge of Hindi.

Dr. Hani Al Halabi

Radiation Oncologist , Gulf International Cancer Center | United Arab Emirates

Dr. Hani Al Halabi is an American board-certified Consultant Radiation Oncologist. He earned his Master of Science and Doctoral Degree in Medicine from McGill University, where he also completed residency training in Radiation Oncology. He is a clinical Fellow of the Massachusetts General Hospital, Harvard Medical School. He worked as Assistant Professor and Radiation Oncologist at the McGill University Health center in Canada before joining the City of Hope National Cancer Center in the USA. Dr. Al-Halabi has authored and served as principal investigator for several research protocols. He has also authored book chapters, peer reviewed publications and abstracts presented at multiple international oncology meetings.

Dr. Hani Osman

Consultant Oncologist , Tawam Hospital | United Arab Emirates

Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum Sudan. He moved to the United Kingdom where he completed his training in internal medicine and obtained his MRCP (UK) degree, Fellowship from the Royal college of pathologists and CCT. He completed his high specialist training in hematology at the University of Cardiff hospital UK. His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was involved and the principle investigator for many clinical trials and he has over 30 publications.

Dr. Hasan Al-Yaseen

Consultant Hematologist , Dubai Hospital | United Arab Emirates

Consultant Hematologist in Dubai Academic Health Corporation/Dubai Hospital, with extensive clinical experience in both benign and malignant Hematology. He is an adjunct associate professor at Dubai Medical College and associate director of the Clinical Hematology Fellowship Program at DAHC. He is also the Co Director of the Dubai Residency Training Program of Internal Medicine at DAHC. He is very active academically both at the undergraduate and postgraduate levels. He has many contributions, presentations and submissions to local and regional conferences. He has several publications as well.

Dr. Hassan Ghazal

Consultant Medical Oncologist & Consultant Clinical Hematologist , King's College Hospital London | United Arab Emirates

Dr Hassan Ghazal is an American board-certified Consultant Medical Oncologist and a Consultant Clinical hematologist offering more than 3 decades of clinical experience. Dr Hassan Ghazal, after doing his basic medical education in American University of Beirut, moved to US for his residency program in Internal Medicine at Sinai Hospital of Baltimore, MD. In 1992, completing the residency program, Dr Hassan Ghazal joined in George Washington university Medical Center for his fellowship in Medical Oncology and completed the same in 1995. He continued in George Washington University Medical Center for another 2 years and obtained his senior fellowship in bone marrow transplantation in the year 1997. He got his US board certification in Internal Medicine, Medical Oncology and in Hematology in the year 1992, 1995,1996 respectively. Except his association with CMC for the preceding 3 years, all his clinical practices were in US in various capacities including Director, Kentucky Cancer Clinic and Staff Oncologist/ Hematologist at Hazard Appalachian Regional Medical Center. Dr Hassan Ghazal is a member of various clinical societies such as American College of Physicians, American Society of Haematology, American Society of Clinical Oncology, European Society of Medical Oncology etc. Dr Hassan Ghazal has got many publications and abstracts in his credit, in peer reviewed journals, and there are many international recognitions and accolades in his name. He has been involved in numerous clinical trials, nearly 100, in the US, serving as Principal Investigator, for over 25 years, and enrolled hundreds of patients in these trials.

Dr. Hassan Hal

Consultant Radiologist , Tawam Hospital | United Arab Emirates

Dr. Hassan Hal is currently a Consultant Radiologist at Tawam Hospital in Al Ain, UAE (from 2015-present), with more than 20 years’ experience in Oncology imaging, and regularly attended GI Tumour MDT meetings both in the USA and UAE. Dr. Hal received his American Board of Radiology certification in 2012 and was fellowship trained in Abdominal Imaging from McMaster University Medical Center (Hamilton, Canada: from 2003 – 2005). Dr. Hal accepted a position as Assistant professor of Radiology at Penn State Hershey Medical Center (Hershey, USA: 2007 - 2015). Dr. Hal has special interest in GI/GU imaging, hepatobiliary imaging, as well as CT colonoscopy.

Dr. Heidi Kussman

Naturopathic Physician , Novomed | United Arab Emirates

Dr Heidi Kussmann is a licensed Naturopathic Doctor in good standing to practice since 2002 and a cancer survivor since 2020. Dr Kussmann works for Novomed and is licensed to practice in good standing in the UAE (DHA & DOH) Canada (inactive) and the USA(active, Vermont). Dr Kussmann is board-certified in naturopathic oncology since 2010 (Fellow, American Board of Naturopathic Oncology) and recertified in 2020.

Dr. Hidayath Ansari

Consultant Radiologist , Cleveland Clinic Middle East | United Arab Emirates

Dr. Hidayath Ali Ansari is Consultant Radiologist, Chief of Nuclear Medicine at the Imaging Institute of Cleveland Clinic Abu Dhabi and Medical Director of Cleveland Clinic Abu Dhabi ( AlAin Branch). Prior to his career in UAE; Dr. Ansari worked as a Consultant Radiologist and Clinical Director for the Department of Radiology at the University Hospitals of Morecambe Bay (NHS) Trust in Lancaster, UK and as Chair of the Radiology, Lancashire Cancer Network. He completed his residency and Fellowships in Specialist Radiology Training at Manchester with PET-CT fellowship at the University Hospital Zurich in Switzerland. His areas of Specialist Expertise include PETCT, Nuclear medicine, CT Colonography and MR Enterography. He has worked with his team to establish Cardiac blood flow quantification, American College of Radiology accreditation, contrast enhanced PETCT and new isotope services including DAT Imaging for Parkinsonism, Sentinel node mapping and hybrid imaging amongst few recent achievements and are working towards establishing Gallium PETCT for prostate and Neuro endocrine tumors. He has been recently awarded Clinical Excellence award for 2019 for recognition of his contribution. He is a fellow of Royal College of Radiologists, actively involved in education and research. He received Four NHS Clinical Excellence Awards from University Hospitals Morecambe Bay NHS in-between 2009 and 2014 in recognition of exceptional contributions to patient safety, quality of clinical care and education.

Dr. Hind El Malik

Consultant, Medical Oncologist , National Center for Cancer Care and Research | Qatar

Hind Elmalik is a Consultant Medical Oncologist at the National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation in Doha, Qatar, with special interest in gyne-oncology. Dr Hind is a Sudanese American. Born in Khartoum, Sudan where she had her early schooling, she went on to graduate from Qasr Al Aini in Cairo, Egypt. After a few years of rotation in various subspecialties, she joined the Arab Board Fellowship program in Internal Medicine at HMC and obtained her Certification in 2006. In the same year she also obtained her MRCP (UK). She then decided to take up Medical Oncology as a subspecialty and finished her Clinical Fellowship in Medical Oncology at the NCCCR in 2012 and was promoted to consultant. She then obtained the Certificate of the European Society for Medical Oncology and the Specialty Certificate in Medical Oncology from the Royal College of Physicians of the United Kingdom. She became interested in Gynecologic Oncology and joined the gyne-oncology multidisciplinary team and runs a specialized joint gyne-oncology clinic with gynecology surgeons, as well as general oncology clinics. Her research interests focus on gynecological cancer, mainly ovarian cancer.

Dr. Holly Meany

Pediatric Oncologist , Children's National Hospital | USA

Since coming to Children’s National as a fellow in 2003, Holly Meany, M.D., is now an attending physician in our Oncology division, associate professor, director for the Solid Tumor Program, and fellowship program director for Pediatric Hematology-Oncology.

Ms. Hosn Saif Eddine

Quality Director , Tawam Hospital | United Arab Emirates

"Mrs. Hosn Saif Eddine is the Quality Director at Al Ain Region composed of 4 Hospitals and managed by Abu Dhabi Health Survives Company (SEHA), the largest network in the UAE. Mrs. Hosn is in charge of developing, overseeing and coordinating the Quality and Patient Safety program including continuous quality improvement, clinical quality and patient safety, Clinical quality review, Risk and Safety Management, Infection Control and customer service improvement. She has a Master Degree in Healthcare Management from the Royal College of Surgeons in Ireland and a Bachelor of Nursing Degree from Lebanon. Hosn also has multiple certifications such as Certified Professional in Healthcare Quality (CPHQ), Certified Professional in Patient Safety (CPPS), Certified Medical Quality (CMQ) and Balanced Scorecard Professional. Hosn has over 30 years in Healthcare and 15 years’ experience in quality, risk management and patient safety. She is a member of National Association for Healthcare Quality, Institute for Healthcare Improvement, American Board for Healthcare Quality and American Society for Healthcare Management. Hosn was an author and co-author for researches and had the opportunity to present at local and international conferences."

Dr. Husam Marashi

Consultant Physician, Oncology Clinic , Tawam Hospital | United Kingdom

Dr Husam Marashi is a Consultant Clinical Oncologist based at the Tawam Hospital. He underwent post graduate training at the West of Scotland hospitals and became a consultant in 2015. He developed a special interest in the non-surgical management of Upper gastro-intestinal and Breast malignancies including chemotherapy, radiotherapy, targeted therapy and immunotherapy. He is a principle investigator for many clinical trials and involved in many precision medicine programmes. He is also an active member of the oligometastasis SABR radiotherapy team. Dr Marashi has an active role in medical education/training for clinical oncology trainees in Scotland, and a member of RCR recruitment team. He is a member of the breast cancer MCN advisory board for the West of Scotland. He developed a special interest in the non-surgical management of Upper gastro-intestinal and Breast malignancies including chemotherapy, radiotherapy, targeted therapy and immunotherapy. He is a principle investigator for many clinical trials and involved in many precision medicine programmes. He is also an active member of the oligometastasis SABR radiotherapy team. Dr Marashi has an active role in medical education/training for clinical oncology trainees in Scotland, and a member of RCR recruitment team. He is a member of the breast cancer MCN advisory board for the West of Scotland.

Dr. Hussain Aby Ali

Chief of Diagnostic Radiology , Tawam Hospital | United Arab Emirates

Dr. Hussain Ali Aby Ali is consultant Radiologist at Tawam Hospital since 2016. He graduated from Jordan University of Science and Technology as a Doctor of medicine and has a Master degree from Jordan University of Science and Technology in diagnostic radiology, Arab Board in radiology and medical imaging and Oncology imaging fellowship from King Hussein Cancer Center (KHCC). He became a chair deputy in 2018, physician lead in 2020 and the Chief of diagnostic radiology 2022 till present. He is also the Chair of head and neck MDT since 2020. His main interest is oncology imaging, chest, neuroradiology and head and neck radiology.

Dr. Ibrahim Alananzeh

Assistant Professor , University of Wollongong in Dubai (UOWD) | United Arab Emirates

Dr Ibrahim Alananzeh is Assistant Professor at the University of Wollongong in Dubai (UOWD). He has a keen interest in cancer care, clinical research, patients quality of life. Dr Alananzeh obtained his PhD from Western Sydney University, studying the unmet supportive care needs of Arab people affected by Cancer. His key focus is person-centred learning, teaching and practice and the ‘flipped classroom/learning’ pedagogy proposed by Flipped Learning Network (FLN). Dr Alananzeh has extensive track record in cancer patient needs and survivorship research particularly among CALD communities. Over the years, he has published numerous articles in international peer-reviewed journals. Dr Alananzeh has a successful track record with a work history that includes both clinical and academic positions, such as oncology nurse, Lecturer at Western Sydney University and University of Wollongong in Australia.

Dr. Ignacio Gil Bazo

Head of the Department of Oncology , Valencian Institute of Oncology | Spain

Prof. Gil-Bazo is the Head of the Department of Oncology and Scientific Director of the Valencian Institute of Oncology (IVO) in the city of Valencia, Spain. He has previously served as Chairman of the Department of Oncology at the University of Navarra, in Pamplona, Spain. In addition, he is Associate Professor of Medicine at the Department of Oncology at the University of Navarra School of Medicine and Director of the New Therapeutic Targets Laboratory of the Program in Solid Tumors at the Center for Applied Medical Research (CIMA). Prof. Gil-Bazo is a Medical Oncologist with expertise in Thoracic Oncology, Translational Research in Oncology and Clinical Investigation. The Valencian Institute of Oncology (IVO), an OECI accredited Cancer Center, is a nationally and internationally renowned institution, the largest and most prestigious private cancer center in Spain.

Dr. Ikram Burney

Senior Consultant in Medical Oncology , Sultan Qaboos University Hospital | Oman

"Dr. Ikram Burney is a Senior Consultant in Medical Oncology at Sultan Qaboos University Hospital (SQUH). He graduated from Pakistan and received his training in Medical Oncology at the Aga Khan University in Karachi, Hammersmith Hospital in London, and Southampton University Hospital. He has been working at SQUH since 2003 and his area of interest includes Lymphoproliferative disorders, Gynecological malignancies, Sarcoma and Melanoma, and Supportive care in Oncology. He has more than 90 publications in peer-reviewed journals."

Dr. Imran Hussain

Respiratory Consultant , University Hospital of North Midlands | United Kingdom

Dr Hussain Graduated from St Georges Hospital, London, and under took training in the UK, including training posts at The Royal Brompton Hospital. During training he undertook a PhD with Professor Holgate in Southampton on RSV immunobiology, he continues to have an interest in severe asthma. He has held consultant posts in Manchester and Stoke on Trent, where has led the respiratory department and involved in senior medical management. He has interests in medical education and been on the national training committee for respiratory medicine. During his consultant tenure he has lead the department, and region for lung cancer care and developed one of the local sites for lung cancer screening in England and guides and supports the region as national lung cancer screening is rolled out across England.

Dr. Indu Oommen

Specialist Radiologist , Tawam Hospital | United Arab Emirates

Dr. Indu Elizabeath Oommen MBBS, MD (Radiodiagnosis) Dr. Oommen has over 9 years experience in diagnostic radiology. Special Interests: are Abdominal Radiology, Neuroradiology and Chest Radiology

Dr. Intikhab Mohsin

Professor of Anesthesiology , Albany Medical Center | USA

.

Dr. Itrat Mehdi

Senior Consultant , Royal Hospital | Oman

Dr. Itrat Mehdi is currently working as Senior Consultant and head of Medical Oncology, National Oncology Center the Royal Hospital Muscat-Oman. He did his medical graduation (MBBS) from Karachi Pakistan in 1986. He had his postgraduate Oncology training in United Kingdom. He has Fellow ships from UK (FRCP – Edinburgh, FRCP London and FRCP – Glasgow), and PhD from London. He has a vast experience in Oncology practice, and clinical research. He is member of many international organizations like ASCO, ESMO, ESACC, OSO, etc. He is on editorial board of many international and indexed clinical journals like BMJ, JPMA, JPMR, World Journal series, SQUMJ, OMJ, J Nephrology Urology and Transplant, biomarkers, and biochemistry. He has been part of many collaborative research studies and clinical trials. He has supervised more than 10 postgraduate students in their postgraduate studies. He has been an examiner in postgraduate examinations in Oncology. He has attended and presented numerous papers/posters in local and international meetings. He has 81 publications in local and international journals.

Mr. Jadallah Ali Alnasarat

IT Health Informatics , SEHA | United Arab Emirates

Mr. Jadallah is a pharmacist with around 13 years’ experience in healthcare IT, EMR including oncology protocols design, pharmacy applications and clinical decision support systems.

Dr. Jamal Alkoteesh

Consultant and chief of Interventional Radiology , Tawam Hospital | United Arab Emirates

Dr Jamal ALkoteesh is one of the founder of Interventional Radiology speciality in UAE and he is the longest served (15 YEARS) Interventional Radiologist in SEHA/Abu Dhabi Emirates .He was the first DOH licensed Interventional Radiologists in Abu Dhabi Emirates. Dr. ALkoteesh started working in SEHA as the chief of Interventional Radiology at Sheikh Khalifa Medical city between 2007-2010 where he also managed and established the first Radiology Residency Program in Abu Dhabi Emirate and become the first Radiology residency program director in 2009 when took the challenge to train UAE junior doctors to become the Radiologists of the future.

Dr. Jamilah Riromar

Consultant Medical Oncologist , National Oncology Center | Oman

Dr Jamila Rir Omar is a consultant medical oncologist with special inters in improving metastatic cancer patient’s outcomes. She has joined genitourinary + gynecology subspeciality, in National Oncology Center Muscat, Sultanate of Oman since September 2019. She has obtained 2 years fellowship program in Genitourinary medical oncology from university of Toronto Canada, May 2017- June 2019. She has completed 5 years speciality residency program in medical oncology from university Claude Bernard Lyon 1, republic of France with DES French board in medical oncology. She completed internal medicine training program from Oman Medical Speciality Board (OMSB) in august 2009 with MRCP-UK February 2009.

Dr. Jason Freedman

Pediatric Oncologist , Children’s Hospital of Philadelphia | USA

Jason Freedman, MD, MSCE is a Pediatric Oncologist and serves as the Inpatient Medical Director of Oncology/Stem Cell Transplant at the Children’s Hospital of Philadelphia. His clinical focus is Cell Therapy and Transplant and pediatric supportive care, and he has a particular interest in epidemiologic and translational research within pediatric supportive oncology and aims to advance the understanding and treatment of symptoms, infections, nutrition, and organ toxicities in pediatric cancer and stem cell transplant patients. Dr. Freedman is also a leader in clinical quality and process improvement, and optimization of clinical operations. Dr. Freedman serves on several committees within the Children’s Oncology Group and is Vice-Chair of the Pediatric Study Group within MASCC (Multinational Association of Supportive Care in Cancer). He is also the PI/Co-PI of collaborative institutional trials focused on supportive care and organ toxicity in HSCT. Dr. Freedman has authored several textbook chapters, many peer-reviewed articles on the supportive care of children with cancer and quality improvement in pediatric oncology, and has contributed to the development of clinical guidelines to standardize management of symptoms and toxicities associated with cancer therapy and stem cell transplant.

Dr. Jaume Capdevila

Medical Oncologist , Vall d’Hebron University Hospital | Spain

Jaume Capdevila obtained his medical degree in the University of Lleida, in Catalonia, Spain. In 2000-2001 held a fellowship in the department of biochemistry and molecular biology at the University of Lleida. From 2002 to 2006 he attended a specialization in medical oncology at the “Santa Creu and Sant Pau University Hospital”, Barcelona and since 2006 served as medical oncologist at Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO) in Barcelona. Since early 2013 he is also leading the gastrointestinal and endocrine tumor unit at Teknon Cancer Institute. He is involved in research and treatment of patients with gastrointestinal cancer and endocrine tumors as well as in early-drug development. He has published over 160 articles in peer-reviewed journals and several book chapters. He is an active member of several oncology societies (ASCO, ESMO, ENETS, EORTC, SEOM, TTD, GEMCAD, GETNE) and actively participates an leads national and international trials. He is member of the Executive Committee of the European Neuroendocrine Tumor Society (ENETS), the chair of the Spanish Task Force for Neuroendocrine and Endocrine tumors (Grupo Español de Tumores Neuroendocrinos, GETNE) Treasurer of the Executive Committee of GEMCAD (Multidisciplinary Spanish Taskforce for the Treatment of Digestive Tumors) and responsible of the rectal cancer group track.

Prof. Javier Cortes

Head of Breast Cancer Unit , International Breast Cancer Centre | Spain

Dr. Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996, specialist in Medical Oncology by the Clínica Universitaria de Navarra, and awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. From June 2003 to July 2015, he has worked in the Department of Medical Oncology at the Hospital Vall d'Hebron, Barcelona, where he has been Coordinator of the Teaching and Training Programme for Residents in Oncology. In addition he was the Head of the Breast Cancer Program from July 2006 to August 2015. From September 2015 to October 2018, he has been Head of the Breast Cancer and Gynecological tumors at Ramon y Cajal University Hospital in Madrid. Dr. Cortes was the Head of the Breast Cancer Program at IOB Institute of Oncology, Quironsalud group, in both Madrid and Barcelona, from 2011 to September 2020. He has been Senior Clinical Investigator of the Breast Cancer Research Program at Vall d’Hebron Institute of Oncology from 2011 to February 2022. Dr. Cortés is the Head of the International Breast Cancer Centre (IBCC) in Barcelona, founding partner of Medica Scientia innovation Research (MedSIR), a company involved in the clinical development of clinical trials. In addition to his medical specialties, he has two master degrees in “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona. He is the author of more than 400 publications, especially about breast tumours and new drugs and more than 800 communications at different conferences. He actively participates in the development of numerous international clinical trials, and he is an ad hoc reviewer of various oncology journals, including, New England Journal of Medicine, Lancet, Lancet Oncology, Annals of Oncology or Journal of Clinical Oncology, among many others Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO). In addition, he is a member of the Scientific Committee of the European Society for Medical Oncology (ESMO), of the Scientific Committee of the European Breast Cancer Conference (EBCC), has been chair for breast cancer at the ESMO 2020 congress, and co-chair of the same section in the congress of the American Association for Cancer Research (AACR) 2020, as well as the immunotherapy area of the AACR 2021 congress. He is a member of the expert panel that develops the treatment guidelines for metastatic breast cancer of the European Society for Medical Oncology, member of the ABC Conference, member of the ASCO International Affairs Committee, member of the executive panel in charge of SABCS Strategic Planning, and co-organizer of the Annual Congress of Controversies in Breast Cancer (CoBrCa). In addition, according to the American Expertscape 2002 ranking, he is considered the world’s leading expert on HER2+ and fourth world oncologist with the greatest expertise in breast cancer.

Dr. Jawaher Ali Ansari

Chief of Oncology Department , Tawam Hospital | United Arab Emirates

Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.

Dr. Jean-Philippe Pignol

Radiation Oncologist , Sultan Qaboos Comprehensive Cancer Center | Oman

Radiation Oncologist-Sultan Qaboos Comprehensive Cancer Center

Dr. Jeffrey Dome

Paediatric Oncologist , Children's National Hospital | USA

Dr. Jeffrey Dome is senior vice president of the Center for Cancer and Blood Disorders at Children’s National Hospital in Washington, DC. He is Professor of Pediatrics at the George Washington University School of Medicine and the Thomas Willson and Lenore Williams McKnew Professor of Pediatric Oncology. Dr. Dome received his MD degree from the University of Pennsylvania School of Medicine and PhD degree in Medicine from Erasmus University in Rotterdam. He completed a residency in Pediatrics at Yale-New Haven Hospital and completed a fellowship in Pediatric Hematology/Oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past-Chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome currently serves as the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters, and chapters on pediatric cancer.

Dr. Jeremy Abramson

Director - Center for Lymphoma , Massachusetts General Hospital | USA

Dr. Abramson is Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center, and Associate Professor of Medicine at Harvard Medical School. Dr. Abramson earned his medical degree from the Mount Sinai School of Medicine in New York City and a Masters Degree in Medical Sciences from Harvard Medical School. He completed a residency in Internal Medicine at the Massachusetts General Hospital in Boston, followed by a fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute. Dr. Abramson's clinical and research interests are in non-Hodgkin lymphomas, Hodgkin lymphoma, and CLL. His research involves the design and conduct of clinical trials of new cancer therapies and cellular immunotherapies in these diseases

Dr. John Devine

Consultant - Maxillofacial, Head and Neck Surgeon - Chair of Division , Sheikh Shakhbout Medical City | United Arab Emirates

Consultant - Maxillofacial, Head and Neck Surgeon - Chair of Division

Dr. John Edwards

Consultant Thoracic Surgeon , Northern General Hospital | United Kingdom

Mr John Edwards was appointed Consultant Thoracic Surgeon in Sheffield, United Kingdom in 2006. He was awarded a PhD in Oncology from the University of Leicester. Current committee memberships include the IASLC, EORTC and NCRI. He is past Chair of the Board of Trustees of the British Thoracic Oncology Group. He is a devoted recruiter to many clinical trials, with particular experience in those comparing surgery to no surgery. He gained a commendation in the 2014 NIHR Cancer Research Excellence in Surgical Trials awards and received the Dan Idhe Lectureship Award at the World Conference on Lung Cancer in 2015.

Dr. John Glaholm

Consultant Clinical Oncologist , The Royal Marsden | United Kingdom

Dr John Glaholm is a Consultant Clinical Oncologist at The Royal Marsden Hospital in London UK and specialises in Radiotherapy treatment of lymphomas. He completed undergraduate training at Charing Cross Hospital, London, and postgraduate training in Clinical Oncology at The Royal Marsden Hospital. He subsequently became a Consultant Clinical Oncologist at The Queen Elizabeth Hospital, Birmingham, UK, where he primarily specialised in Head and Neck cancer, Colorectal cancer and Urological malignancies. He held the post of Honorary Senior Lecturer at the University of Birmingham, UK. He has authored/co-authored over 70 peer reviewed publications and has written several textbook chapters. In addition to his current clinical work at The Royal Marsden Hospital he is a Module leader, lecturer/tutor and examiner for the Institute of Cancer Research Master of Science degree course in oncology. He has a strong interest in clinical trial participation.

Dr. John Kelly

Professor of Uro-Oncology , University College London | United Kingdom

John Kelly is Professor of Uro-oncology at University College London and Honorary Consultant Urologist at University College London Hospital. He was head of the Department of Urology at UCLH to 2020 and Director for robotic surgery at the Chitra Sethia Centre. UCLH is the UKs largest centre for Robotic pelvic surgery, JK has expertise in complex pelvic surgery and integrates high quality clinical activity with translational research. John Kelly is the clinical lead for Urology for NHS England. JDK leads a biosensor research group research group investigating linkage between biometric and genomic alterations related to wellness and cancer outcomes. He is the principal investigator for four multicentre randomised controlled trials (CRUK funded) and was Chair of the NCRI Bladder Cancer Clinical Study Group. He holds the Orchid Chair of Urology at Barts Hospital, Queen Mary University London. JDK received his medical degree from The Queen’s University of Belfast. He was awarded The Professor Geoffrey D. Chisholm Prize, The Calvert Medal and the Ethicon Foundation Prize. He was a recipient a British Urological Foundation Award following which he completed a Fellowship at the New York Presbyterian Hospital – Weill Medical College of Cornell University, New York. He was a Senior Lecturer in Uro-Oncology at Cambridge University prior to his appointment to Chair at UCL.

Dr. Jose Vercher

Consultant Nuclear Medicine Physician , Hospital Universitari de Bellvitge | Spain

Dr Vercher is a nuclear medicine physician in the Department of Nuclear Medicine/PET Unit of the University Hospital of Bellvitge (Barcelona, Spain). During his residency period he obtained a scholarship from the Colegio Oficial de Médicos de Valencia and was invited by the Mount Sinai Medical Hospital in New York in the Department of Radiology. Since 2010 he was working at the University and Polytechnic Hospital La Fe in Valencia (Department of Nuclear Medicine - Clinical Area of Medical Imaging), being also a member of the "Biomedical and Imaging Research Group - (Gibi230)". Subsequently, he completed a fellowship in the Department of Radiology at the UH Hospital/Case Western Reserve University in Cleveland (Ohio, USA), specializing mainly in PET/MR and digital PET. His interests are focused, but not limited, to the field of oncology with hybrid imaging techniques such as PET/CT, PET/MR, SPECT/CT, FDG and non-FDG radiopharmaceuticals, and radiometabolic therapy (PRRT for neuroendocrine tumors, radioligands for prostate cancer, endocrine disorders and endocrine oncology, treatment of bone metastases, microspheres with Y-90/Ho-166 for the treatment of intrahepatic tumor lesions, among others). In addition, in the field of research he participates in several clinical trials of both imaging and treatments, and recently involved in dosimetry and artificial intelligence projects (radiomics, etc). He has presented more than 100 papers to both national and international congresses. Since 2019, Dr Vercher is the Spanish ambassador of the European Society for Hybrid, Molecular and Translational Imaging (ESHIMT), and since 2020 its Vice-President, now in a second term; in addition to being a member of the Scientific Subcommittee on Hybrid, Molecular and Translational Imaging for the European Society of Radiology (ESR-ECR). Since 2022, he is the National Ambassador for the Oncidium Foundation, an international foundation dedicated to promoting the use of radiopharmaceutical radiotherapy and connecting patients, professionals and experts in the field of nuclear medicine to improve access to cancer treatments and clinical trials worldwide.

Ms. Jumanah Alajmi

Acting Manager of Pharmacy , Tawam Hospital | United Arab Emirates

"Ms. Jumanah Al Ajmi has a bachelor degree of pharmacy from King Saud university in Riyadh , Master of Science in Healthcare Administration, University of Atlanta and MBA from Al Ain University. She is an acting pharmacy manager, with more than 25 years of experience ,hardworking , has the ability to adapt to all situations that face the pharmacy ,participated in educational ,training of students and preceptor for the pharmacy residents . "

Mr. Khaldoun Delki

Quality Manager , Tawam Hospital | United Arab Emirates

Quality Manager at Tawam Hospital

Mr. Khaled Al Qawasmeh

Clinical Research Nurse , Tawam Hospital | United Arab Emirates

Khaled Al Qawasmeh qualified with Master’s Degree in Clinical Oncology Nursing from the University of Pennsylvania, Philadelphia, USA. He is an Oncology Certified Nurse (OCN) since 2009. Khaled has gained the prestigious Clinical Research Certification by SOCRA USA. Khaled is currently the president of the Emirates Oncology/Hematology Nursing Society.

Dr. Khaled Al Zwae

Consultant Physician , Tawam Hospital | United Arab Emirates

Dr. Khaled Al Zwae is a UK trained FRCE CCST Consultant Radiologist currently working at Tawam Hospital, Abu Dhabi, UAE.

Dr. Khaled Aldahmani

Consultant Endocrinologist , Tawam Hospital | United Arab Emirates

Dr.Khaled Aldahmani is a consultant endocrinologist and chairman of academic affairs at Tawam hospital. He is an adjunct associate professor at the college of Medicine and health sciences, UAE University. He obtained his medical degree from UAE University and then completed his internal medicine residency training at university of British Columbia in Canada. He then finished his subspecialty training in endocrinology and metabolism at Dalhousie University followed by a one year combined clinical and research fellowship training in pituitary disorders and thyroid cancer at the same university. He is an American and Canadian board certified in internal medicine and endocrinology. Dr.Aldahmani is the President of the Gulf Association of endocrinology and diabetes (GAED). Also he serves as the scientific committee chairperson of the Emirates Diabetes and Endocrinology Society (EDES) and is a board member at Arab thyroid Association. Dr.Aldahmani has special interest in clinical research. He is a cofounder and chairman of the annual Al-Ain Internal medicine research conference since 2016. He published >20 papers in various medical journals. He sets on the editorial board of journal of diabetes and endocrine practice in addition to being a reviewer for many local and regional journals.

Dr. Khalid Abdel Galil

Oral Maxillofacial Surgeon , Tawam Hospital | United Arab Emirates

Dr. Khalid Abdel-Ghalil is a Consultant Maxillofacial/ Head & Neck/ Reconstructive Surgeon at Tawam Hospital UAE and Adjunct Academic Faculty at the University of Sharjah. His Sub-specialty interest lies in Head & Neck Oncology/Reconstruction, including microvascular free tissue transfer following ablative oncologic surgery. He also providing regional Level I trauma cover as well as Educational Supervisor to Oxford OMF & Undergraduate trainees at Oxford University Hospitals NHS Foundation Trust.

Dr. Khalid Al Saleh

Consultant Hematologist and Medical Oncologist , King Saud University Medical City | Saudi Arabia

Prof. Khaled AlSaleh received his Bachelor Degrees in Medicine and Surgery with an Honor degree from King Saud University, Riyadh, KSA in 2000. He completed his training in Internal Medicine (2007), Hematology (2008) and Medical Oncology (2010) at McMaster University, Hamilton, Ontario, Canada. He is Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) as well as Fellow of the American College of Physicians (FACP). Subsequently, he received his Master of Science Degree in Health Research Methodology in 2011 and completed a Fellowship in Lung Cancer with Clinical Investigator Program (CIP) from the Royal College of Physicians of Canada in 2011. Prof. Khaled AlSaleh has long Clinical, Research and Administrative experience including establishing and being the first Director of the Oncology Centre as well as Head of the Academic Hematology and Oncology Division at King Saud University Medical City, Riyadh, KSA. Beyond Administrative and Clinical duties, he has been deeply involved in National and International research programs as Principal Investigator of the International Cancer Research Group (ICRG). He participated in the creation if this Research Group involved in 9 countries including 7 countries of the Middle-East/North Africa (MENA) region and 2 countries in Europe (France, Germany). In this context, He led the first large-scale Randomized Phase III trial in Oncology designed, performed and completed in the MENA region with 2 international publications. Additionally, he is deeply involved in the Program of “Fusion of Fundamental Physics with Artificial Intelligence in early detection of cancer using Liquid Biopsies”, including: • 7 International Proof of Concept (POC) studies for early detection of Breast, Colon, Pancreas, Stomach, Liver, Lung, Ovary and Prostate cancers as well as one Large-scale Phase III trial for early breast cancer detection using Quantum Optics and Artificial Intelligence, • 7 International POC studies for early detection of Breast, Colon, Pancreas, Stomach, Liver, Lung, Ovary and Prostate cancers as well as one Large-scale Phase III trial for early breast cancer detection using Raman Laser Spectroscopy and Artificial Intelligence.

Dr. Khalid Saeed Balaraj

Chair of Oncology Service , Tawam Hospital | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Mr. Khalid Al Habaybia

Nurse Manager , Tawam Hospital | United Arab Emirates

Mr. Khaled is currently a Nurse Manager within the Paediatric Haematology-Oncology Unit at the Tawam Hospital, United Arab Emirates. Prior to this, Khaled graduated from the Faculty of Nursing at the University of Jordan in Amman, Jordan before going on to obtain a Master’s of Science in Healthcare Administration at the University of Atlanta in the USA, with ongoing second master’s in the science of Global Child Health at St. Jude Academy, Memphis-USA. He actively participates in many haemophilia-focussed groups, taking on the role of Nurses Committee Member for the World Federation of Haemophilia (WFH), and General Secretary and Haemophilia Nurse at the United Arab Emirates Haemophilia Group. Khaled is also the Chairperson for the Nursing Care Working Group initiated by the Paediatric Oncology Eastern Mediterranean (POEM) Group, which aims to continuously improve paediatric oncology care, research, training and advocacy in the eastern and Mediterranean region by means of integrated teamwork. Khaled a leadership consultant for the development of health services and medical personnel at the Arab Leadership and Foresight Agency which aims to improve health care in Low and Middle Income Countries (LMICs).

Dr. Khalifa Alkaabi

Radiation Oncologist , Tawam Hospital | United Arab Emirates

Radiation Oncologist at Tawam Hospital

Dr. Khurram Siddiqui

Senior Consultant Urologist , Sultan Qaboos University Hospital | Oman

Dr. Khurram is currently working as Senior Consultant Urology at Sultan Qaboos University Hospital and since 2017 he is also the general secretary of Oman urology Society (OUS). After completion of basic training in Pakistan at the Aga Khan University Hospital (AKU), he obtained FRCS in 2000 and FEBU in 2003. He was awarded the society international urologie (SIU) fellowship in 2003. In 2005, he was selected by Society of Endourology to do a fellowship at Duke University, USA. Later he also completed society of urologic oncology (SUO) recognized fellowship at Western University, Canada. Currently he is working as Senior Consultant urologist at Sultan Qaboos University Hospital with main interest in urologic oncology. He has more than 50 peer reviewed publication, 10 book chapters and 4 research grants. He has presented research papers in almost all major urological conference. He has also contributed to some large industry sponsored clinical trials and has received more than 75000 USD in research grants.

Mr. Lameen Abdul-Malik

Chief Executive Officer , Honest Management | United Arab Emirates

Muhammed Lameen Abdul-Malik is a Nobel Peace Prize Laureate, with over 20 years of experience in international management working in the UK Government, United Nations in nuclear science and technology and the Future Investment Initiative (FII) Institute, an International Saudi Think Tank. He is a leader with a strong track record of high delivery, highly distinguished and qualified professional with expertise across Project Management, International Development, Public Sector Policy, Client Relations, Training & Development, Strategic Planning and Policy Analysis. M.B.A.-level educated in international management with a broad set of skills in international affairs and diplomacy and founder of 100 ideas café (a crowd sourcing platform enabling ideas to impact 1 billion people) and the CEO of Honest Management FZ LLE, UAE.

Dr. Layla Al Reyami

Hematology/Oncology , Tawam Hospital | United Arab Emirates

Dr. Layla Alreyami has been working as pediatric hematologist/Oncologist since she was in residency post graduate specialization program for almost 10 years ago. Since then she has been running full oncology & hematology services as inpatient & outpatient. Her experience has been enhanced with her graduating from clinical fellowship program from UOT-University of Toronto / The hospital of Sick Children Toronto. She has multiple published articles in renowned hematology journals about UAE experience in handling bleeding disorders among regional population. She is honored to be working in an organization that allows her to offer various individualized ultimate solutions to patients with various problems concerning hematology oncology illnesses. Her goal is to establish a pediatric Oncology/Hematology center in collaboration with SEHA facilities to provide advanced therapies like BMT & gene therapies in the future.

Dr. Lina Wahba

Clinical Pharmacy Lead , Tawam Hospital | United Arab Emirates

Dr. Lina Wahba is a clinical pharmacy lead and she also works as an adjunct lecturer at the Faculty of Medicine and Health Sciences, United Arab Emirates University. She earned her BSc in Pharmacy from the Faculty of Pharmacy, Jordan University of Science and Technology-Jordan, then had her MSc degree in Clinical Pharmacy from UCL, school of pharmacy/UK. She conducted her clinical training at Barts’ and the London NHS hospital trust-London. Lina is board certified oncology pharmacist. She maintains a primary clinical practice in Tawam oncology unit, and leading the Medication use evaluation committees. Lina has been having a major role in optimizing patient care in addition to creating and updating the oncology protocols. During her career, Lina worked as a clinical pharmacist in different institutions. She established the clinical pharmacy services in the paediatric oncology ward at King Hussein cancer centre- Amman/Jordan. She has many publications in addition to different abstracts that had been presented in the UK clinical pharmacy association conference, the American Society of Health System Pharmacists association (ASHP), Emirates Oncology Conference, and in the Journal of Oncology Pharmacy Practice (JOPP). Finally, Lina is the principal pharmacist in a number of Phase III multinational RCTs which are involving investigational chemotherapeutic and targeted agents.

Ms. Lubna Yousef

Breast Cancer Nurse Navigator , Tawam Hospital | United Arab Emirates

Ms. Lubna Yousef is a Breast Cancer Nurse Navigator working at Tawam Hospital, Al Ain, UAE. Her key responsibilities include • Help decrease the patient’s fear and anxiety • Facilitate interaction and communication with clinic staff and screening providers • Assist patients with any state/charitable applications necessary to receive screening. • Follow-up with patients after referral out lines • Build trust and rapport with the patient through one-on-one interactions. • Assist the patient in preparing for appointments. • Assess patient’s best method of learning • Provide education on coping with cancer, what to expect during chemotherapy and radiation, and dealing with the side effects of treatment. • Identify resources for financial assistance, medication needs, home health care, transportation and other concerns. • Refer patients to support groups, classes and other programs for information and support

Dr. Lutfi Kurban

Consultant Radiologist , American Hospital | United Arab Emirates

Dr. Lutfi Kurban is a Consultant Radiologist trained in the UK and has a wide experience in General Radiology at a consultant level since 2004. He has an interest in body cross sectional imaging with specialized areas of interest in chest, hepato-biliary and urological imaging. He is actively involved in lung cancer research and he was part of the large multicenter UK clinical trial (SPUtNik trial) looking at the diagnostic accuracy and cost effectiveness of Contrast enhanced CT and PET CT in characterization of solitary pulmonary nodule. He also published several papers on imaging and diagnosis of lung cancer.

Dr. M Zafar Javed

Chief of Palliative Care Clinics , Tawam Hospital | United Arab Emirates

Chief of Palliative Care Clinics – Tawam Hospital

Dr. Mahdi Al-Taher

Consultant Colorectal and Oncologic Surgeon , Tawam Hospital | United Arab Emirates

Mahdi Al-Taher MD, PhD, is a consultant colorectal and oncologic surgeon with a special interest in innovative image-guided surgery techniques and minimally invasive approaches. He is currently based in the UAE with continued research activities in IRCAD (Research Institute Against Digestive Cancer, France) and the Maastricht University medical Center (Netherlands). He is a member of the United European Gastro enterology scientific committee as a representative of the EAES (European Association for Endoscopic Surgery). He is a board member of the Dutch Fluorescence-guided Surgery Group and member of the Dutch Surgical Innovation Committee.

Prof. Mahmoud Marashi

Consultant Haematologist , Mediclinic City Hospital | United Arab Emirates

"Prof. Mahmoud Marashi joined Mediclinic City Hospital as Consultant Haematologist with over 30 years experience in haematology. He established the clinical haematology service in Dubai Health Authority which is involved in the management of both benign disorders (anaemias, bleeding disorders, thrombosis/thrombophilia) and malignant disorders (acute and chronic leukaemias, myeloma, myeloproliferative disorders, myelodysplastic syndrome). He runs both an undergraduate and postgraduate training in Haematology. Prof. Marashi did his undergraduate training in Andhra University, India. His haematology training was done in the UL at Heartlands Hospital, Birmingham, (formerly East Birmingham Hospital), The West Midlands Blood Transfusion Service, Edgbaston, Birmingham, The John Radcliffe Hospital and Chuchill Hospital in Oxford, UK. Prof. Marashi has been involved in medical education for over 20 years. He is a Professor of Medicine and Haematology and is the Head of the Academic Department of Medicine, Dubai Medical College / Dubai Health Authority. He is also an external examiner for the Royal College of Physicians of UK. *Independent Doctors (ID): Defined as individuals not employed by Mediclinic Middle East who are granted the privilege to treat patient at MCME facilities, in either inpatient or outpatient settings, as applicable."

Dr. Majed Al Ghamdi

Assistant Professor and Consultant Radiation Oncologist , Princess Norah Oncology Center | Saudi Arabia

Dr. Alghamdi, MD, MBA, FRCPC, DABR is an assistant professor and consultant radiation oncologist with a sub-specialization in treating central nervous system (CNS) tumors and stereotactic radiosurgery. He completed his residency training at university of Calgary, Alberta, Canada in 2016 and his fellowship training at university of Toronto, Ontario, Canada in 2017. He holds Canadian and American boards in radiation oncology. He has published three textbook chapters and numerous peer-reviewed manuscripts that mainly focused on CNS oncology. Recently, Dr. Alghamdi completed masters degree in business administration from prince Mohammad Bin Salman College of Business and Entrepreneurship.

Dr. Majed Alremeithi

Paediatric Haematology/Oncology , Tawam Hospital | United Arab Emirates

Dr. Majed AlRemeithi is currently serving as a Specialist in Paediatrics Haematology and Oncology at Tawam Hospital. With a strong educational background, he completed his paediatrics residency at Tawam Hospital and received Jordanian board certification. Driven by a deep passion for his field, he is dedicated to providing comprehensive healthcare for the past 5 years to his young patients with haematological disorders and cancer, constantly staying updated with the latest advancements.

Mr. Majed Mohammed

Advocacy & Scientific Affairs Executive , Friends of Cancer Patients | United Arab Emirates

Mr. Majed Mohammed Ibrahim is the Advocacy and Scientific Executive at the Friends of Cancer Patients (FOCP) organization in the UAE. Educational background includes: Master of Science in Public Health, and a Bachelor of Science in Medical Sciences. With a wide network of regional and global memberships & partnerships, Majed is an active committee member at the WHO NCD Labs Steering Committee, an active member in UAE Rare Disease society, a Young Leader in NCD Child program, CCI Asia Regional Committee Member (ASRC). His major role in FOCP is focused on reducing the impact of cancer through organizing & supporting local and international advocacy endeavors to ensure that cancer patients’ voices are heard and valued to drive better change.

Dr. Majeda Al-Ruzzieh

Chief Nursing Officer , King Hussein Cancer Center | Jordan

Majeda A. Al-Ruzzieh, Ph.D., RN is the Chief Nursing Officer at King Hussein Cancer Center (KHCC) with over 20 years of experience in nursing. She led the journey toward nursing excellence at the center which was concluded in 2019 by achieving Magnet® Recognition with exemplary results. This recognition made KHCC the first hospital in Jordan . Additionally she established the first Oncology Nursing Residency Program in Jordan accredited with DISTINCTION from ANCC in US Since 2003, she has effectively led more than 1,100 specialized nurses at KHCC, who work tirelessly to provide compassionate care of the highest quality to patients. Dr. Majeda has a PhD in Nursing and additionally a Certificate Holder in Fundamentals of Magnet® from ANCC. Currently candidate for Patient Centered Care Fellowship. A winner for HRH Princess Muna Award for best leader in Jordan .

Ms. Manal Rayyan

Clinical Pharmacist , Tawam Hospital | United Arab Emirates

Dr Manal Rayyan, MSc clinical pharmacist, BCPS ,certified oncology profient from HOPA with extensive Clinical pharmacy experience in Oncology field and palliative service, and appointed as Adjunct lecturer in UAE university and preceptor in ASHP accredite Seha Pharmacy residency program PGY1 . Dr Manal has received her bachelor of Pharmacy Degree in 2005 from University of Jordan then Master degree of clinical pharmacy in 2011 from same university in her home country Jordan,completed american pharmacotherapy board certification 2021, and HOPA oncology profient certification 2022 . She has excelled in numerous roles including working As a community pharmacist, hospital pharmacist, investigational pharmacist and clinical pharmacist and held different managerial role during her journey. She is a member of the SIOP member & Oncopharm task force, and holds certifications in Research from national institute of health NIH and American board of pharmacology 2021, also hold several preceptor and training competencies that enable her to provide a quality education and training to her colleagues in her practice scope. In addition to clinical & leadership skills, she has demonstrated commitment to academic practice by participating in research projects that have contributed to development and application of evidence for several patients’ quality of life and safety initiatives.

Mrs. Manar Ashour

Paediatric Oncology / Haematology Nurse Navigator , Tawam Hospital | United Arab Emirates

Ms. Manar is currently a Pediatric Hematology / Oncology Nurse Navigator within the Pediatric Hematology-Oncology Unit at the Tawam Hospital, United Arab Emirates. Prior to this, Manar graduated from Fatima Collage of Health and Science of UAE in Al-Ain, before going on to obtain an Executive Masters in Health Care Administration (EMHCA) at Zayed University of Abu Dhabi in the UAE. Manar began her professional career in Tawam hospital on Oct, 2003 20 years ago. Manar has been working as Charge Nurse in Pediatric Oncology / Hematology Units prior to be Nurse Navigator in 2021. Manar works as the middle person between the patient families and clinical care staff. Manar helps navigate the patient families through the treatment process by connecting them to resources and Education, information to make informed decisions. In addition to, Manar worked as assessor /preceptor for new employee and nurses students, Team Leader of Quality Improvement Group within the organization. Moreover, she is an active member of SIOP group, Speaker in International Medical Conferences and workshops.

Dr. Marco Stellato

Medical Oncologist , Fondazione IRCCS Istituto Nazionale dei Tumori | Italy

Dr. Marco Stellato is a Medical Oncologist in the Medical Oncology department at the Fondazione IRCCS Istituto Nazionale dei Tumori in Mailan, Italy. At present, he is doing PhD in Bone Metastasis Pathophysiology from University Campus Bio-Medico, Rome

Ms. Mariam Aiash

Clinical Nurse Educator , Tawam Hospital | United Arab Emirates

Mariam Aiash - Clinical Nurse Educator in Pediatric hematology Oncology and polyclinic from February 2019. Qualified with BSc Nursing. And has 17 years of experience in clinical nursing. She joined Tawam in October 2005 as GNI in Pediatric Medical and moved to peds oncology unit in 2006. Being in educator role actively participating in all educational activities like Hospital Orientation programs, workshops, competencies, simulations, Grand rounds etc.. As per the learning needs identified the gaps conducted teaching sessions by liaising with Nurse Manger Mariam is actively involved in the Orientation programme for the new staff, educational activities contributing to the unit, and as a Preceptor. Being a preceptor was able to precept nursing interns and new staffs. She is also a committee member of the Nursing Midwifery Education & Research Unit (NMERU) at Tawam Hospital She received her bachelor degree in nursing in 2008 from Fatima College for health science. She received her diploma in health organizations management in 2017. She received her Master degree in healthcare administration in 2019 from Swiss Business College. She received her Master degree in healthcare professional education from Ajman Medical University in 2022. She presented her poster in 2019 in SINMAC She was a speaker in 2nd and 3dr POEM. She presented (central line care) in 2023 in SINMAC

Ms. Mariam Al Harbi

Research Manager , SEHA | United Arab Emirates

Mariam Al Harbi is a board certified paediatrician currently serving in the role of Research manager in Abu Dhabi Health Services Co. (SEHA) in addition to her part time practice in ambulatory paediatrics. Her current work entails overseeing all clinical research activities in SEHA varying from ethical review of projects, clinical trials, governance and data monetization in addition to industry engagement with stakeholders. She completed further training in clinical research in Harvard Medical School with a focus on clinical trials. She was selected to be part of the National Artificial Intelligence Program in the UAE lead by Oxford University and completed her training of the program and serves as part of the AI network initiate in UAE. Mariam completed her master degree in Leadership and Innovation in Healthcare from RCSI and is currently finishing her executive education program with London Business School. She is also an adjunct assistant professor in the College of Medicine Khalifa University. She has several publications and serves as a reviewer for different journals. She sits in Abu Dhabi Research Committee and Abu Dhabi Department of health research and innovation grant committee.

Dr. Mariam Almarashda

Consultant Thoracic Surgeon , Tawam Hospital | United Arab Emirates

Dr. Mariam Almarashda MBBS ABHS (CTh) was graduated from College of Medicine and Health Sciences, UAE University, in 2006. Finished her Arab board training in General Surgery 2013 from The General Surgery Integrated program in the Emirate of Abu Dhabi, UAE. Followed by Clinical Fellowship in Thoracic Surgery in Vanderbilt University, Tennessee, USA with clinical Research fellowship in Both Lung cancer and Oesophageal Cancer, in 2016. She was appointed as Consultant Thoracic Surgeon in SEHA in September 2016. She is Associate Professor in UAE University College of Medicine & Health Sciences. She has held several senior management role and organizer of international workshops in advanced thoracic surgical techniques including Chest wall trauma Surgery. Beside her Clinical Leadership, she has Special Interest in Medical Education, She is the Lead of ACGME- I Surgical training Program in Emirates of Abu Dhabi since 2013. Program Director of the integrated General Surgery Program since 2017. She is the Chair of Scientific committee for Surgical Programs for the NIHS Emirati board in UAE and Lead of Surveyor’s for Both NIHS Institutional and Program accreditation in the Country.

Ms. Maricon Absalon

Acting Nurse Manager , Tawam Hospital | United Arab Emirates

"Maricon Absalon is working as Acting Nurse Manager in Oncology Unit and Palliative Care Unit of Tawam Hospital with an overall experience of 32 years .She is ONS certified. She joined Tawam in 2004 as a RN in Hematology unit. She has extensive experience and skills with various divisions within oncological care. She completed many Quality Improvement Project aimed at standardizing Clinical care in Oncology Division. "

Mrs. Mehad Araki

Palliative and End of Life Coordinator , Tawam Hospital | United Arab Emirates

Mehad Araki is a compassionate oncology palliative care nurse, with extensive clinical experience in the field of oncology, haematology and palliative nursing. She received her degree of Master of Science in Nursing, specialty of Adult Health Nursing from RAK Medical and Health Science University. In 2011 Mehad obtained her degree of her bachelor’s in nursing (BSN) from Griffith University and a degree of diploma in nursing in 2008 from the institute of nursing in UAE Mehad is passionate about advocacy and education in Palliative care. She participates in nursing researches and variety of quality improvement projects and initiatives. Currently Mehad works as a palliative outreach nurse and End of life coordinator at Tawam Hospital in Alain, to enhance and improve patient’s outcome through continuum of care, from early in the course of illness until death.

Dr. Mehran Habibi

Chief of Breast Surgery , Northwell Health | USA

Dr. Mehran Habibi is the Chief of the Breast Program, Florina Rusi Marke Comprehensive Breast center, Staten Island University Hospital, NY and Chief of Breast Surgery, Northwell Western Region, Director of International Program Development, Breast Surgery. Dr. Habibi specializes in breast surgical oncology, with expertise in treating complex breast cancer cases including wirefree and Oncoplastic Breast conserving surgeries, Nipple Sparing and Risk reducing mastectomies, Hidden scar surgery, Nerve preserving mastectomy and intra operative margin assessment. His research interests include Tumor genomics, Microbiome, Axillary management after neoadjuvant chemotherapy and intra op margin assessments.

Dr. Mhairi Simpson

Nurse Consultant , NHS Lanarkshire | United Kingdom

Dr Mhairi Simpson is a registered nurse of 30 years in Scotland, UK. Six years in generalist cancer care and 24 years in specialist cancer care. She is currently a Nurse Consultant, working clinically in upper GI oncology, has a strategic role in cancer services and is professional nursing lead for cancer nursing in the 3rd largest health board in Scotland, NHS Lanarkshire. She has research interests in the nursing contribution to cancer care; patient reported outcomes and peoples’ experiences of cancer care.

Dr. Michael Grimley

Professor of Clinical Pediatrics , Cincinnati Children's Hospital | USA

Michael Grimley, MD, is a Professor of Pediatrics at the University of Cincinnati, Department of Pediatrics. He is the Medical Director of the Division of Bone Marrow Transplant and Immune Deficiency at Cincinnati Children's Hospital Medical Center. Dr. Grimley is an experienced clinician specializing in the care of children undergoing hematopoietic stem cell transplant (HSCT) with a clinical research interest in the treatment and prevention of opportunistic infections associated with HSCT. He is the head of hemoglobinopathy transplant team at CCHMC and served as the institutional PI for its sickle cell gene therapy clinical trial. His clinical interests include BMT for primary immunodeficiencies, hemoglobinopathies and leukemia. He also is PI for multiple Phase 2 protocols using Virus specific T cells (VSTs) directed against Adenovirus, CMV, EBV and BK virus at Cincinnati Children's Hospital Medical Center.

Dr. Mimma Rizzo

Medical Oncologist , Azienda Ospedaliera Universitaria Consorziale | Italy

Dr. Mimma Rizo is a Medical Oncologist at Azienda Ospedaliera Universitaria Consorziale, Italy.

Dr. Mohamed Aseafan

Consultant Medical Oncology , Security Forces Hospital | Saudi Arabia

Dr. Mohamed Aseafan is a Consultant in Medical Oncology at Security Forces Hospital in Riyadh, Saudi Arabia. He has interest in GI/GU/GYNE. He graduated from Alfaisal University in Riyadh. He did a Saudi Fellowship in Medical Oncology from Saudi Commission for Health Specialties - Riyadh

Dr. Mohamed Shelan

Senior Radiation Oncology Consultant , University of Bern | Switzerland

"PD Dr. Shelan holds the position of Senior Radiation Oncology Consultant at the University of Bern, Switzerland, and boasts nearly 13 years of comprehensive experience within the field of radiation therapy. This experience has been acquired through roles held at esteemed university hospitals in Germany and Switzerland, renowned for their unwavering dedication to evidence-based, high-caliber oncological care. Beyond his clinical responsibilities, PD Dr. Shelan has made substantial contributions as an educator. Since 2017, he has served as a dedicated tutor for medical students at the University Hospital Bern. Furthermore, PD Dr. Shelan has actively engaged as a principle investigator in a range of clinical and translational research endeavors. This involvement has spanned retrospective and prospective studies conducted at both national and international levels. He has also demonstrated his commitment to advancing the field as an author of numerous peer-reviewed publications and has lent his expertise as a reviewer and editor for esteemed international journals. PD Dr. Shelan possesses a specialist interest in Genitourinary, Lung, and Head & Neck cancers"

Dr. Mohammad Asha

Consultant Physician, Neurosurgery Clinics , Tawam Hospital | United Arab Emirates

Consultant Physician, Neurosurgery Clinics Tawam Hospital

Mr. Mohammad Mah'D Saleh

Oncology Center Manager , Tawam Hospital | United Arab Emirates

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.

Dr. Mohammed Al Nuaimi

Consultant Physician , Tawam Hospital | United Arab Emirates

"Dr. Mohammed Al Nuaimi is a consultant physician in Pediatric Hematology & Oncology, Bone Marrow Transplant and Cellular Therapy, at Tawam Hospital, Al-Ain, UAE. He completed his general pediatrics residency training, pediatric hematology & oncology fellowship & Bone Marrow Transplant and Cellular Therapy fellowship at The Hospital for Sick Children (SickKids) Toronto, Canada. Dr. Al Nuaimi holds the Canadian and American Boards of general pediatrics, and the Canadian board in Pediatric Hematology & Oncology. He has a special interest in bone marrow failure diseases, bone marrow transplant and celluar therapy. Dr. Al Nuaimi is a member of several professional societies including Children's Oncology Group (COG) and American Society of Hematology (ASH). He has completed and ongoing research activities and gave many talks in his speciality.

Dr. Mohammed Ashour

Consultant Medical Oncologist , Kuwait Cancer Control Center | Kuwait

Consultant Medical oncologist Kuwait cancer control center. Prof. Clinical Oncology Alzhar University. Cancer research diploma Harvard University. Member of ASCO and ESMO. Interested in GU&GY malignancy. Has many publications in peer review journal.

Dr. Mohsen Zikry

Professor of Clinical Oncology , Azhar University | Egypt

Dr Mohsen Zikry is a renowned Professor of Oncology at Azhar University.With a career dedicated to cancer research and patient care. Professor Mohsen Zikry’s work has been published in numerous prestigious journals.In addition to his research and clinical work ,Dr Mohsen Zikry is actively involved in training and mentoring the next generation of oncologists in Egypt.

Dr. Mouza Mohd Al Ameri

Consultant Physician, Oncology – Breast Care Center (Dep) , Tawam Hospital | United Arab Emirates

Mouza Al Ameri is a breast onco-plastic surgeon and assistant professor of surgery in UAE University and Tawam Hospital. She is passionate about breast cancer research, empowering breast cancer survivors and disseminate breast cancer awareness among society members.

Dr. Muath Alnassar

Consultant Medical Oncologist , Kuwait Cancer Control Center | Kuwait

Dr.Muath Alnassar is currently working as head of Thoracic , Head & neck and sarcoma unit at Kuwait Cancer Control Center. He completed residency oncology program from western ontario university in canada 2016

Dr. Mudhasir Ahmad

Medical Oncologist , VPS Lifecare Hospital | United Arab Emirates

Dr. Mudhasir Ahmad is a Specialist in Medical Oncology at LLH Hospital, Musafffah. He started his career as a Senior Registrar of Medical Oncology/BMT at Indraprastha Apollo Hospitals, Delhi, India. He later joined Apollo Hospitals, Hyderabad, India, as a Medical Oncologist. He later joined HCG, Delhi, India, as a Consultant Medical Oncologist and worked as a Senior Consultant Medical Oncologist at Fortis Hospital Noida, Delhi, India.

Dr. Muhammad Faisal Khanani

Chief of Hematology/Oncology PEDS , Tawam Hospital | United Arab Emirates

Chief of Hematology/Oncology PEDS – Tawam Hospital

Dr. Mustafa Baroudi

Consultant Pediatric Oncologist Hematologist , NMC Royal Hospital | United Arab Emirates

Dr Mustafa Baroudi is a Consultant Pediatric Oncologist Hematologist at NMC Royal Khalifa City, Abu Dhabi, UAE.

Dr. Muwafak Salman

Division Chief - Urology Clinic - Medical Affairs , Tawam Hospital | United Arab Emirates

Dr. Muwafak Salman, Consultant Urology, Andrology, Infertility and Men’s Health and Chief of Urology Department at Tawam Hospital.⁣ Dr. Salman has more than 16 years of experience ,in addition to, being certified by the Arab Board of Medical Specialties, with specialization in Surgery and the European board of Urology. He has completed his fellowship from the Royal College of Surgeons in Ireland, as well as, being a member in the American Urological Association.⁣

Dr. Muwaffaq Al-Ani

Consultant Physician , Tawam Hospital | United Arab Emirates

Dr. Muwaffaq Radeef Abdu Al Ghafoor Al-Ani is an Oral Maxillofacial Surgeon currently working in Tawam Hospital, Al Ain.

Dr. Nadeem Pervez

Radiation Oncologist , Cross Cancer Institute | Oman

Dr. Nadeem Pervez qualified in Radiation Oncologist from Ireland and Canada. He worked in Ireland, Canada and Middle East at various academic levels. He served as radiation oncologist at Cross Cancer Institute and Associate Professor at University of Alberta, Edmonton, Alberta, Canada. His clinical work includes treating cancer of various sites with emphasis on breast and prostate cancer. He was a prominent member of Prostate Cancer Brachytherapy seed implantation treatment in Canada. He is initiating Prostate Brachytherapy treatment in the Middle East. He co-chaired breast cancer group in Alberta and contributed to Alberta Breast Cancer Treatment guidelines. He was involved in invention of newer radiotherapy machines. Nadeem was actively involved in contributing to Resident Training program and Clinical Research Fellowship program in Radiation Oncology at the University of Alberta, Canada. He was awarded best teacher award from residents to acknowledge his contributions. He oversees research projects from international fellows. His residents and fellows later appointed at key academic, clinical and leadership positions across world. He was invited as scientific speaker in multiple countries. Nadeem is actively involved in clinical research. He was able to secure multiple competitive research grants from awarding agencies. He was leading investigator initiated studies and involved in multi-institutional cooperative group studies. He published multiple research articles in reputed journals. He served in institutional ethics committees, research funds granting agencies, medical student selection committees, oncology conference scientific committee and peer-reviewed several Oncology journals. He is founding member in establishing Middle East Society of Therapeutic Radiation Oncology (MESTRO).

Dr. Nadeem R Abu-Rustum

Gynecologic Surgeon , Memorial Sloan Kettering Cancer Center | USA

Nadeem R. Abu-Rustum, MD, is the Chief of the Gynecology Service and Avon Chair in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center. He also serves Professor of Obstetrics and Gynecology at Weill Cornell Medical College. Dr. Abu-Rustum received his medical degree from the American University of Beirut in Lebanon. He completed his residency in obstetrics and gynecology at the Greater Baltimore Medical Center in Maryland and a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center. Dr. Abu-Rustum’s clinical research focuses on innovative surgical approaches, including sentinel node mapping, improved localization and visualization of tumors, fertility-sparing surgery, and laparoscopy. He also has numerous contributions to the field of gynecologic cancer surgery for which in 2017 he received the Society of Gynecologic Oncology SGO Innovation Award for his work on sentinel node mapping of uterine cancer. In his current role at Memorial Sloan Kettering Cancer Center, he is actively involved in the development and improvement of surgical techniques and oversees surgical research programs. Over the years he has built collaborations with numerous gynecologic oncology teams in Europe and worldwide and in 2019 he was awarded the AGO Austria Wertheim award. Dr. Abu-Rustum is Chair of the NCCN Cervical/Uterine/Vulva/GTD Cancers Panels and has served as a member of the Gynecologic Oncology Group Cervix Committee and the American College of Surgeons Committee on Emerging Surgical Technology and Education. He has authored or co-authored more than 450 publications and is co-author to numerous book chapters and three textbooks in gynecologic oncology. He has worked at Memorial Sloan Kettering Cancer Center for more than 25 years and is in full-time practice of gynecologic oncology in New York.

Ms. Nadia Al Shamsi

Quality Improvement Officer , Tawam Hospital | United Arab Emirates

Nadia Al Shamsi is a Sr. Continuous Quality Improvement Officer at Tawam Hospital. She has Degree of Master of Science in Quality & Safety In Healthcare Management from Royal College of Surgeons in Ireland, Bachelor Degree in Human Resources Development, Diploma in Computer Information Processing and Certificate in General Business Information Technology. Prior to joining Tawam she worked as Employee Relations Officer in Human Resources Department at Al Ain Hospital for 5 years and for 2 years in the Health Insurance Industry.

Dr. Najam Awan

Paediatric Oncology , Tawam Hospital | United Arab Emirates

Dr. Najam Ahmed Muhammad Ahmed Awan's specialty is Pediatrics and currently works as a Pediatrician Oncologist at Tawam Hospital, Al Ain, UAE